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Peptides that self-assemble into pore-like structures in lipid bilayers could have utility in a variety 
of biotechnological and clinical applications due to their ability to breach the barrier imposed by 
lipid bilayers. To empower such discoveries, we have used synthetic molecular evolution to select 
for the pHD peptides, a family of membrane-active, pore-forming peptides that assemble into 
macromolecular-sized pores at acidic pH. We have also discovered the macrolittins, a related 
family of peptides that form macromolecular-sized pores at all pH. To understand the mechanism 
of action of these “pHD peptides”, we systematically explored structure-function relationships 
through measurements of the effect of pH and peptide concentration on membrane binding, 
peptide structure, and the formation of macromolecular-sized pores in neutral POPC membranes. 
We find that at low pH, the peptides bind to membranes, fold into alpha helices, and 
cooperatively assemble into pores. The major role of pH is to regulate the amount of peptide 
bound per vesicle, with 50% leakage of 40 kDa dextrans occurring at only 75 peptides bound per 
vesicle. Since cell membranes are complex, composed of lipids with various headgroups and acyl 
chains, we also sought to determine the effect of anionic headgroups and acyl chain length on the 
mechanism of action of the pHD peptides We find that pHD15 retains its pH-sensitivity, and is 
extremely sensitive to the composition of the bilayer. The peptide partitions equally favorably to 
anionic and neutral membranes, and is equally potent in 1:9 POPG:POPC and POPC membranes, 
but less potent in 1:9 POPS:POPC membranes. The peptide binds to membranes of various 
thicknesses in a pH-sensitive manner that is affected by the chain lengths. Leakage is decreased 
for thicker membranes, which cannot be accounted for by the amount of peptide bound. Overall, 
we find that the physical chemistry and sequence of the pHD peptides, as well as the lipid 
composition affects the peptides’ potency and pH dependence. The sequence-structure-function 
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relationships described here can be used for future design and optimization of membrane 
permeabilizing peptides for specific applications. 
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Membranes as Semipermeable Barriers 
Membranes are essential to life, permitting the earliest forms of life to arise1, the development of 
eukaryotic life forms with subcellular compartments2, and the rise of complex neural signaling 
networks that, at their root, depend on the precise spatial and temporal separation of ions across 
the neural membrane3. Fundamental to all of these functions is the necessity to differentiate inside 
from outside, a critical role of the membrane.  
 One essential barrier property of membranes is that they are selective of what they permit 
across, a characteristic known as semipermeability3. Due to their inherent hydrophobicity, 
membranes permit the passive diffusion of small, relatively hydrophobic molecules such as 
steroids, and prohibit the passage of hydrophilic and large molecules. The properties that would 
enable a molecule to passively enter cells has been of interest to drug developers, who wanted to 
discover rules that would allow a drug to be orally active. Such drugs must cross several 
membranes, such as the intestinal lining and the vascular epithelium4. In 1997, Christopher A. 
Lipinski proposed several guidelines as the Rule of 55. These rules state that molecules must be 
smaller than 500 daltons, have a moderate hydrophobicity such that its octanol-water partition 
coefficient or log[P] < 5, and have less than 5 hydrogen bond donors or 10 hydrogen bond 
acceptors. Many common orally active, over-the-counter drugs such as ibuprofen, aspirin, 
acetaminophen, dextromethorphan (a cough suppressant), diphenhydramine (an antihistamine) 
obey these rules. Although Lipinski’s rules are useful for predicting what types of molecules may 
go across, they emphasize the narrow range of molecules that membranes would allow to 
passively diffuse into the cell.  
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Although most molecules are barred from entry, cells require nutrients and metabolites 
that cannot passively diffuse across the membrane to be brought into the cell. Nature has designed 
pathways for these molecules to cross the membrane, but they typically require that the molecule 
has high specificity for the binding sites of membrane transporters or channels, and sometimes 
the input of energy in the form of ATP3,6,7. The result is that healthy cells maintain the 
composition of molecules that are inside the cell. However, there are circumstances during which 
destabilizing the membrane to permit the passage of molecules could be useful to disrupt the 
homeostasis of diseased cells.  
For example, the destabilization of the plasma membrane of cancer cells could result in 
the cells’ death as the ions, nutrients, and other molecules diffuse out of the cell8–11. Membrane 
destabilization could also be useful in expanding the number of druggable targets12. Many 
intracellular targets that reside beyond the plasma membrane are largely unreachable by high 
molecular weight, hydrophilic molecules such as nucleic acids, sugars, and proteins12,13. These 
molecules cannot cross the membrane by passive diffusion, and are excluded from entry by 
membrane channels and pumps or via endocytosis if they are unable to bind to recognition 
domains of membrane receptors. Some of these molecules get internalized into cells via 
endocytosis. However, these molecules remain unable to penetrate the endosomal membrane and 
therefore remain trapped within endosomes, and eventually degraded as the endosome matures 
into lysosomes2,14. Disrupting the structure of the endosomal membrane would enable the escape 
of therapeutic molecules to the cytosol. 
In either of the above examples, the indiscriminate disruption on any cell membrane 
would be toxic and limit the therapeutic usefulness of this method. To prevent such a harmful 
event from occurring, the destabilization of membranes can be triggered to form in response to a 
signal such as pH – a signature of the cancer microenvironment15–19 and the endosomal 
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lumen2,20,21. Beyond their use in the clinic, such pH-triggered, membrane-destabilizing agents 
could be used in biotechnology as biosensors, among other uses22–25. 
Approaches for Designing Membrane Destabilizing Agents 
Several approaches have found limited success in disrupting membranes based on pH. 
Synthetic polymers have been used to burst endosomes via the proton sponge effect26, and pH-
triggered liposomes have been designed to release their contents to the cytosol by fusing with and 
destabilizing the endosomal membrane27,28. However, the endosomal release of cargo remains 
challenging14,29. 
An additional approach would be to use peptides. Peptides have a number of advantages. 
They are chemically stable, antigenic10, straightforward to synthesize, and easy to derivatize to 
add novel functionalities. Nature has also produced hundreds of peptides which are known to 
form pores, typically as a first-line of defense against pathogens before the immune system kicks 
in30,31. Consequently, there is a vast number of peptides from which an ideal pore-forming 
sequence could be identified. Their properties can be modified by swapping a residue with one of 
20 amino acids. Furthermore, peptides are small in size, which would permit their entry into 
tumors32, which are known to have poorly developed, leaky vasculature.  
One challenge in using pore-forming peptides, however, is that the mechanism by which 
they form pores is not well understood, and even highly controversial. Take for example melittin, 
the main component of bee venom. Melittin is a 26 amino acid, alpha-helical peptide known to 
form small pores in membranes that cause the disruption of ion gradients, resulting in the cell’s 
death. The mechanism of action by which melittin forms pores is not well understood in part 
because its behavior is sensitive to a number of experimental conditions such as pH, lipid 
composition, ionic strength, temperature, and peptide concentration33. Furthermore, the 
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transmembrane, pore-competent state is short-lived. Oriented circular dichroism indicates that the 
transmembrane state is a minor component of the total peptide population, with the vast majority 
of peptide oriented parallel to the surface of the bilayer34,35. Furthermore, electrochemical 
impendence spectroscopy has recorded that pore-formation occurs within seconds after peptide 
interacts with membranes, and the pores close soon after36. Melittin has been proposed to 
destabilize membranes by forming toroidal pores, carpeting the bilayer, or through a detergent 
effect. 
 For designing membrane-active peptides, the absence of detailed information about the 
sequence-structure relationships of pore-forming peptides poses a design challenge: it is difficult 
to identify the key residues responsible for forming the pore, or for stabilizing the peptide-lipid 
and peptide-peptide interactions37. Therefore it is difficult to identify the residues to modify to 
optimize the peptide’s function. To overcome this roadblock, membrane-active peptides can be 
designed by synthetic molecular evolution. This approach has been highly successful in designing 
membrane-active peptides, including those designed to spontaneously translocate across 
membranes while attached to cargo38, beta-sheet pore-forming peptides39, soluble, potent pore-
forming peptides40, and cell penetrating peptide nucleic acids41. The rationale behind this 
approach is to create hypotheses about the role of the residues, select alternative resides that may 
bestow novel properties to the peptide, then create a combinatorial library with thousands of 
members. A high-throughput assay is designed to select outliers that excel at the properties which 
are desired.  
The Road to Discovering the pHD Peptides 
 The pHD peptides are second-generation derivatives of melittin. Originally, gain-of-
function melittin variants were selected through a high-throughput screen in which peptides that 
formed large, potent, equilibrium pores were selected for33. MelP5, like melittin, is a 26 amino 
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acid peptide, but can allow the escape of 10 kDa dextrans from vesicles at P:L as low as 1:500042. 
The peptide forms pores in a pH-independent manner. To encode pH-sensitivity, Wiedman et al. 
attempted to rationally design variants, taking inspiration from the pH-sensitive peptides GALA 
and pHLIP23. GALA, derived from a viral fusion peptide, forms small pores at acidic pH43. 
pHLIP, a peptide derived from bacteriorhodopsin, is not a pore-forming peptide, but inserts into 
membranes at acidic pH18. The rationally designed variants of MelP5, named MelP5_Δ4 and 
MelP5_Δ6, had 4 or 6 acidic residues. This attempt at rational design was only partially 
successful. The peptides bound to membranes and folded into alpha helices in a pH-sensitive 
manner, but lost their ability to form large pores, underscoring that the properties of pore-
formation and pH-sensitivity and stable pores are not fully additive23. Consequently, we decided 
to try a high throughput approach to create gain-of-function variants of MelP5 that were large, 





pH-sensitive, pore-forming peptides can be useful for a variety of applications as biosensors, drug 
delivery agents, and cancer therapeutics. However, due to the technical challenges of probing the 
interaction of membrane active peptides with the lipid milieu, structure-function relationships 
between amino acid sequence and pore-forming activity are difficult to characterize. 
Consequently, the rational design of pore-forming peptides remains challenging.  
The primary objective of my thesis research was to discover a novel class of pH-sensitive 
peptides that form large, stable pores in membranes. In this thesis, I will describe the discovery of 
the pHD peptides – or the pH-dependent Delivery peptides – through synthetic molecular 
evolution.  In Chapter 2, I will describe the discovery of the pHD peptides from a 18,432 member 
library of peptides. The peptides were selected with a high-throughput orthogonal screen 
designed to identify the peptides with exceptional ability to induce no leakage at neutral pH, and 
abundant leakage of 40 kDa macromolecules at acidic pH. We learn that the peptides share a 
common motif of 5 or 6 acidic residues that accounts for pH-sensitive macromolecular-sized 
pore-formation. We also discover the closely related group of peptides, the macrolittins, from the 
same library of peptides. The macrolittins are potent pH-insensitive pore-formers that have three 
acidic residues which lie along the center of the acidic face of the helix. This may suggest that the 
central acidic residues are involved in forming potent, macromolecule-sized pores, and the 
flanking acidic residues of the acidic face of the pHD peptides modulate pH-sensitive activity. 
A second objective was to understand the structure-function relationships of the pHD 
peptides on neutral membranes. In Chapter 3 I describe the characterization of the behavior of the 
pHD peptides on neutral POPC membranes with circular dichroism, tryptophan fluorescence, and 
leakage assays. We find that under acidic conditions, the peptides bind to the membrane, fold into 
alpha helices, and cooperatively assemble into macromolecular-sized pores. Ultimately, the 
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activity of the peptides depends on the number of peptides bound per vesicle, which can be tuned 
with pH, peptide to lipid ratios, and peptide sequence. Activity is high under conditions of acidic 
pH, high peptide to lipid ratios, and 5 rather than 6 acidic residues. 
Cell membranes are highly complex environments, composed of proteins, sugars, and 
many types of lipids with various acyl chains and headgroups. Therefore the final objective of my 
thesis was to evaluate the effect of anionic headgroups and acyl chain length on the behavior of 
one pHD peptide, pHD15. In Chapter 4, I describe my findings that the peptide is less active on 
anionic membranes, despite the same partitioning of peptide on neutral and anionic membranes. 
This suggests that anionic headgroups interfere with the insertion or association steps of pore-
formation. We also find that pHD15 partitions less favorably to and is less active on membranes 
composed of lipids with longer acyl chains. 
The discoveries of the pHD peptides and the macrolittins diversifies the toolbox of 
peptides that can be used for biotechnological and clinical applications. Furthermore, the 
principles underlying pHD peptides’ pore-formation on membranes will be useful for the future 




MATERIALS AND METHODS 
Here I collect the materials and methods used throughout the following chapters. Many of these 
protocols have been published in the following papers:  
J. Am. Chem. Soc. (2017) Vol. 13, No. 92, pg. 937-945 
J. Am. Chem. Soc. (2018) Vol. 140, No. 20, pg. 6441-6447 
J. Am. Chem. Soc. (2019) Vol. 141, No. 16, pg. 6706-6718. 
Materials 
Peptides of > 95% purity were purchased from BioSynthesis, Inc. The lipids 1-palmitoyl-2-
oleoyl-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-(9,10-dibromo) stearoyl-sn-glycero-3-
phosphocholine (diBrPSPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG), 1,2-dimyristoleoyl-sn-
glycero-3-phosphocholine (14:1 (Δ9-Cis) PC), 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine 
(16:1 (Δ9-Cis) PC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (18:1 (Δ9-Cis) PC), 1,2-
dieicosenoyl-sn-glycero-3-phosphocholine (20:1 Cis PC), and 1,2-dierucoyl-sn-glycero-3-
phosphocholine (22:1 Cis PC) were purchased from Avanti Polar Lipids. 8-Aminonaphthalene-
1,2,3-trisulfonic acid (ANTS) and p-xylylenebis(pyridinium bromide) (DPX) were purchased 
from Thermo Fisher Scientific. Chloroform, a mmonium thiocyanate, and other salts and buffer 
materials were purchased from Fisher Scientific or Sigma-Aldrich. TAMRA-biotin-dextran 
(TBD) was synthesized as described elsewhere22,42. 
Buffers 
Thirteen buffers were prepared with pH from 4 to 7 at 0.25 pH increments. Buffers with a pH 
between 4 and 5.5 were prepared with 10 mM sodium acetate, and buffers with a pH between 
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5.75 and 7 were prepared with 10 mM sodium phosphate. Buffers for binding and leakage assays 
were prepared with 100 mM KCl. Buffers for circular dichroism were prepared without KCl, and 
their pH was adjusted with phosphatidic acid instead of hydrochloric acid to minimize the CD 
signal due to the absorption of the chloride ion below 200 nm. All buffers were vacuum filtered 
through a 0.22 m pore size membrane to remove dust and bacteria before use. 
Peptides 
Solutions of ~1 mM peptides were prepared with Millipore water. Concentrations were 
determined using the absorbance of the single tryptophan on each peptide. The average of three 
absorbance measurements at 280 nm on a NanoDrop 2000c (Thermo Fisher Scientific) was used 
to determine the concentration. Peptides were stored frozen until use and were subjected to no 
more than five freeze-thaws to minimize peptide degradation. 
Vesicle Preparation 
Three types of 100 nm large unilamellar vesicles (LUV) were prepared with the lipid 
compositions POPC, 1:9 POPS:POPC, 1:9 POPG:POPS, 14:1 (Δ9-Cis) PC, 16:1 (Δ9-Cis) PC, 
18:1 (Δ9-Cis) PC, 20:1 (Δ9-Cis) PC, or 22:1 (Δ9-Cis) PC. For all vesicle types, POPC in 
chloroform was dried under vacuum overnight, resuspended in buffer, frozen and thawed ten 
times, and extruded ten times through 100 nm poly carbonate membranes.  Vesicles with no 
probes entrapped were used for binding and circular dichroism.  For TBD-encapsulating vesicles, 
dry lipid films were resuspended in buffer containing 1 mg TBD per 50 mol lipid.  After 
extrusion, vesicles were incubated on high capacity streptavidin agarose to remove 
unencapsulated TBD. For ANTS/DPX vesicles, dried lipid films were resuspended in 12.5 mM 
ANTS and 45 mM DPX. After extrusion, unencapsulated ANTS and DPX were separated from 
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the vesicles by size exclusion chromatography with Sephadex G-100 resin. Lipid concentration 
was measured using a modified Stewart Assay44.  
Dextran leakage assays 
Leakage of 40 kDa was measured with FRET. Dextran vesicles with entrapped TBD were diluted 
to 1 mM, and streptavidin-AF488 (the donor fluorophore) was added to a final concentration of 
20 nM.  In a 96-well plate, peptide and vesicles were mixed, then incubated while shaking at 
room temperature for 1 hour before measuring FRET by donor fluorescence quenching on a 
BioTek H4 Synergy Hybrid Microplate Reader with ex/em = 495/519 nm. As a positive control 
for 100% leakage, 4 l of 10% Triton X100 was added to three wells, and as a negative control, 
no peptide was added to three wells. Leakage measurements are the average of at least 3 unique 
vesicle preparations. Fractional leakage was calculated as: 
Fractional leakage was calculated as: 
fleakage = (Fno peptide-Fsample)/(Fno peptide-Ftriton)                  (1) 
The leakage as a function of pH was fit to determine the pH at which leakage is 50% (the 
midpoint or “pH50”): 





      (2)  
Here, Lmax and Lmin are the curve’s maximum and minimum values, respectively, and rate 
describes the steepness of the curve.  
ANTS/DPX Leakage assays 
Small molecule leakage was measured by quenching of ANTS by DPX. ANTS/DPX leakage 
vesicles were diluted to 1 mM. On a 96-well plate, peptide and vesicles were mixed at P:L 
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ranging from 1:50 to 1:5000, then incubated with shaking at room temperature for 1 hour before 
measuring ANTS fluorescence using a microplate reader with ex/em = 360/519 nm. As a positive 
control for 100% leakage, 4 l of 10% Triton X100 was added to three wells, and as a negative 
control, no peptide or Triton was added to three wells. Leakage measurements are the average of 
at least 3 unique vesicle preparations. Fractional leakage was calculated as: 
fANTS/DPX leakage = (Fsample-Fno peptide)/(Ftriton-Fno peptide)   (3) 
The leakage as a function of pH was fit using equation (2) to determine the midpoint of the curve, 
or the pH50. 
Tryptophan Binding 
POPC vesicles were prepared at ~30 mM at pH 4.75 and pH 6.25 as described above. Vesicles 
were diluted to 1 mM with buffers spanning pH 4 to 7, then incubated overnight at 4°C to allow 
the internal and external pH to equilibrate while minimizing vesicle degradation due to 
hydrolysis. The next morning, the pH of the solution was verified with MColorpHast pH test 
strips. Peptide was added with P:L ranging from 1:50 to 1:5000 in 0.5 mL centrifuge tubes. After 
1 hour of incubation at room temperature, tryptophan fluorescence spectra were measured on a 
Horiba Fluorolog 3-22 in a 45 l cuvette. Samples to correct for lipid scattering, including 
vesicles, vesicles with tryptophan (at P:L ranging from 1:50 to 1:5000), and tryptophan (at P:L 
ranging from 1:50 to 1:5000), were also measured at each pH, but without a 1 hour incubation. 
Scattering correction was made as described previously45. The midpoint of the curve, or the 
pH50, was obtained by fitting using equation (2). 
 The nmol of peptide bound was calculated as:  
𝑁𝑏𝑜𝑢𝑛𝑑 = 𝑓𝑏𝑜𝑢𝑛𝑑𝑁𝑡𝑜𝑡𝑎𝑙    (4) 
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Where fbound is the fraction of peptide bound, as determined by the normalized tryptophan 
fluorescence, and Ntotal is the total nmol of peptide in a sample. 
Circular Dichroism 
Vesicles without KCl were prepared as described above for the tryptophan binding. Scans were 
collected in a 1 mm pathlength cuvette on a Jasco J-715 spectropolarimeter with a scan rate of 
100 nm/min, 3 accumulations, at room temperature. After measurement, the scans were corrected 
for background using a vesicle sample with no peptides.  Relative % helicity was calculated by 
scaling the average ellipticity at 222 nm. The midpoint of the curve, or the pH50, was obtained by 
fitting using equation (2). 
Oriented Circular Dichroism 
Mixtures of peptide and lipid were prepared in methanol at P:L = 1:200 for the macrolittins, or at 
P:L = 1:50 for pHD15. Aliquots were dried under vacuum onto a quartz disk for at least 1 hour. 
The disk was sealed in a chamber with a second quartz window. The samples were allowed to 
hydrate for at least 30 minutes through the vapor phase using MilliQ water in the chamber to 
form stacked oriented multibilayers. The quartz disk was oriented perpendicular to the beam and 
CD spectra were collected at eight rotations of the sample holder around the beam axis and 
averaged. Lipid-only spectra, collected the same way, were subtracted.  
 To determine the fraction of peptide that had been inserted into the membrane, the 
hydrated spectra was compared with basis theoretical spectra of fully perpendicular and fully 
parallel orientations of a helix with respect to the membrane surface. A spectra deconvolution 




To determine if the pHD peptides can exchange from vesicles to which they are bound into a 
second population of vesicles added after binding, we measured the change in tryptophan 
fluorescence upon the addition of a second population of vesicles composed of brominated lipids. 
Since bromines quench tryptophan fluorescence46, the exchange of peptides from POPC to 
brominated vesicles will result in quenching. We prepared vesicles composed of POPC or 16:0-
18:0 (9,10 diBr) PC at pH 4.5, and diluted them to 1 mM. To determine the extent of tryptophan 
quenching by the brominated vesicles, 100 l of 1 mM diBrPSPC was mixed with peptide added 
to a final concentration of 20 M (P:L = 1:50). After 1 hour, the tryptophan fluorescence spectra 
were measured as described in the binding assay. To measure the kinetics of quenching, the 
tryptophan fluorescence of pHD15 was measured at 280/334nm. After adding 100 l of 1 mM 
POPC  to a cuvette, fluorescence was measured for up to 5 minutes, and then peptide was added 
up to a final concentration of 20 M. After waiting 30 minutes to ensure maximal binding to the 
vesicles, diBrPSPC or POPC (as a negative control) was added to final concentrations of 0.2 or 
0.33 mM, and fluorescence was measured for 30 more minutes.  
 High throughput screen for the discovery of the pHD peptides 
Library Synthesis 
The peptide library was a one-bead-one- peptide library, synthesized using a split-and-recombine 
approach described in detail previously33,47,48. The library members were synthesized on Tentagel 
Megabead MB NH2 resin beads (Rapp Polymere MB300002), coupled to it by a UV-cleavable 
photo linker, 4- (4-[1-(9-Fluorenylmethyloxycarbonylamino)ethyl]-2-methoxy-5-nitro-phenoxy) 
butanoic acid. After synthesis, side chains were deprotected with a mixture of trifluoroacetic acid 
and scavengers49. Beads were then washed extensively and stored dry at −20°C prior to use.  
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To cleave the photolinker and release the library members, beads were first suspended in 
methanol and dispersed onto a glass plate. The beads were dried thoroughly and then exposed to 
UV light at 365 nm for 6 h with illumination from plate top and bottom. One day prior to 
screening, beads were placed into the wells of a 96-well plate, one bead per well. Water and 
hexafluoroisopropanol (25 μL each) were added to each well, and the plates were exposed to 365 
nm UV light for an additional 3.5 h, releasing and extracting the peptide while also evaporating 
the solvent. Finally, 25 μL of water was added to each well, and the plates were incubated 
overnight for peptide solubilization. About 0.5 nmol of peptide was extracted from each bead, as 
quantified by tryptophan fluorescence.  
High-Throughput Screening 
In the orthogonal high-throughput screen, we combined the two assays described above and used 
them in 96-well format as follows.  
Step 1. Individual beads were separated into the wells of a plate, and peptides were extracted into 
a small volume of water as described above. Each bead releases about 0.5 nmol of one peptide 
sequence from the library.  
Step 2. First, 1 mM POPC lipid vesicles in 100 μL of sodium phosphate buffer at pH 7 was added 
to the peptides in water in the plate from Step 1. These vesicles contained the 350 Da fluorophore 
ANTS and its quencher DPX, entrapped at mM concentrations. After this step, the nominal 
peptide concentration was 5 μM, and the peptide-to-lipid ratio was roughly 1:200. Leakage, if it 
occurs, causes an increase in fluorescence of ANTS. A few wells contained controls: vesicles 
only, 1 nmol of the peptide MelP5 (P:L = 1:100), 4 nmol of MelP5 (P:L = 1:25), or 0.4% v/v of 
the detergent Triton X-100. The latter two should completely permeabilize the vesicles.  
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Step 3. After 60 min of incubation, ANTS fluorescence was measured for each well to quantitate 
small-molecule release using eq 1.  
Step 4. Next, to the same wells, a different preparation of vesicles was added. These vesicles have 
entrapped 40kD TAMRA-biotin- dextran (TBD) and external Alexafluor488 streptavidin. The 
TBD vesicles were in sodium acetate buffer at pH 4 so that the final pH in each assay well was 
5.0. This second addition of vesicles increased the total volume to 200 μL which decreased 
peptide to 2.5 μM and decreased ANTS vesicle concentration to 0.5 mM. The new TBD vesicles 
were present at 1.5 mM so that the total peptide to total lipid ratio was roughly about 1:800.  
Step 5. After 60 min, the intensity of the AF488-streptavidin was measured to quantitate 
macromolecule release, which is calculated with eq 2. This orthogonal and sequential screen 
gives two measurements that are used to identify peptides with the desired properties: (i) small-
molecule release at pH 7 and P:L = 1:200, and (ii) macromolecule release at pH 5 and P:L = 
1:800.  
High-throughput screen for the discovery of the macrolittins 
The library was synthesized as a one bead one sequence library and was screened using a serial, 
two-assay orthogonal screen. First, ~0.5 nmol of each library member in solution was assayed for 
induction of leakage of the small molecules ANTS and DPX (21) from POPC vesicles at pH 7 
and a peptide to lipid ratio (P:L) = 1:200. Second, additional TBD vesicles were added at 30 
minutes to screen for TAMRA-biotin- dextran (40 kDa) leakage at pH 7. The total P:L after the 
second addition was 1:400. For controls we also tested 4 nmol of MelP5 (final P:L = 1:50) for 
near complete macromolecule leakage, respectively. We also tested no peptide for a negative 
control and Triton-X100 detergent for a positive control for complete leakage. After selection of 
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the positive pore forming library members (see Chapter 1) the peptide remaining on the bead was 
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Membrane-permeabilizing peptides could have utility in a variety of biotechnological and clinical 
applications due to their ability to breach the barrier imposed by lipid bilayers50–59. But to enable 
their practical application, they will first need to be designed to function only in specific 
environments, or only in response to specific triggers. One potentially useful trigger is pH, which 
varies in spatially and temporally specific ways in cellular organelles, and also varies locally in 
tissues under some pathological conditions, including cancer60–62. As an example application, pH-
sensitive membrane-permeabilizing peptides could be triggered upon endosomal acidification to 
promote the release of uptaken polar molecules from endosomal compartments into the cell 
cytosol50,63–65. Such an application would eliminate a long-standing barrier to the delivery of 
generic polar compounds, especially proteins and other macromolecules, to cells14,63,66. Indeed, 
while efficient methods exist to deliver oligonucleotides to cells65,67, most other types of 
macromolecules are more difficult to deliver. These macromolecules can be directed to existing 
cellular uptake mechanisms68,69, but in the absence of endosome permeabilization or disruption, 
they often get trapped within the classical pathways that lead to their lysosomal degradation or 
recycling without significant entry into the cytosol70,71. As a second example application, pH-
sensitive, membrane-permeabilizing peptides could potentially be used in cancer therapies to 
selectively permeabilize the plasma membranes of cancer cells. This is possible because the 
environmental milieu in the vicinity of solid tumors is often acidic due to their high rate of mostly 
glycolytic metabolism62. In support of this application, the locally acidic pH of solid tumors has 
already been shown in mice to trigger the pH-sensitive insertion of peptides into membranes, 
although not for peptides that cause permeabilization60,72. 
Some progress has been made in the discovery or design of pH-triggered pore-forming 
peptides73,74 including some that we designed rationally23, and other pH-triggered membrane-
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active peptides65,75. The state-of-the art in the field has been trial-and-error-based addition of 
protonatable residues such as aspartate (D), glutamate (E), and histidine (H). Two well-studied 
examples are pHLIP, which inserts across membranes at pH < 5.5 without permeabilization,11 
and GALA, which permeabilizes synthetic membranes at pH < 5.576. However, none of the 
known pH-sensitive peptides have all of the properties needed for the applications described 
above. For example, pHLIP does not form pores, although it can deliver small polar molecules 
that are covalently attached to it by insertion across the membrane77. GALA, and others, do form 
pores in membranes, but only small pores36,75,76,78,79 with limited utility for cellular delivery, 
especially for macromolecules. 
A uniquely useful combination of properties would be pH-triggered membrane 
permeabilization that enables the movement of macromolecules across membranes. Until 
recently, even nontriggered macromolecular poration activity that occurs at low peptide 
concentration has been rare in pore-forming peptides80,81. However, we recently used high-
throughput screening of a peptide library to discover a unique peptide, called MelP5, which 
allows macromolecules through synthetic membranes even at very low concentrations of 
peptide33,42. Thus, with MelP5, there is at least one sequence known that is a non-pH-sensitive 
macromolecular pore forming peptide. As discussed above, there are also sequences such as 
GALA and pHLIP and others that have pH-sensitive membrane insertion and permeabilization. 
However, we are aware of no sequences, other than those discussed below, that have both 
properties.  
There is a lack of detailed molecular understanding of the sequence−structure−function 
relationships for membrane- active peptides, which hinders their rational design. Here we take a 
novel high-throughput approach to the discovery of pH- sensitive, macromolecular pore-forming 
peptides. First, we used the sequence of the macromolecular pore former, MelP5, and sequence 
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features found in GALA and pHLIP to design a rational combinatorial peptide library. We then 
developed an orthogonal high-throughput screen to identify sequences from the library that have 
the following two properties in synthetic bilayers: (i) little membrane permeabilization at 
physiological pH 7 at high peptide concentration and (ii) efficient formation of macromolecule-
sized defects in membranes at acidic pH 5 and low peptide concentration. Such peptides will have 
no effect on membranes at normal cellular pH, but will be triggered by physiologically reasonable 
acidic pH to form macromolecule-sized pores. We show below that this approach successfully led 
to the discovery of a conserved motif for pH-triggered, macromolecule sized poration. We expect 
these unique sequences to ultimately form the basis for multiple applications that utilize changes 
in pH as a functional trigger.  
Results 
Peptide Library Design 
The peptide MelP5 is a highly potent, gain-of-function variant of the cytolytic bee venom peptide 
melittin that was discovered in a high-throughput screen of a library that used melittin as a 
template.36 While the melittin library was screened only for dramatically increased potency of 
small-molecule release, we later showed that MelP5, the most potent gain-of-function peptide 
discovered, also releases macromolecules from vesicles at low peptide concentration42. Among 
the many known membrane-permeabilizing peptides, Melp5 is unique in its ability to induce the 
passage of dextrans up to a molecular weight of 40,000 through bilayers. MelP5 is unstructured in 
solution, but folds into an amphipathic α-helix in the presence of membranes, into which it 




Previously, we attempted to rationally design pH sensitive, macromolecular pore-forming 
peptides23 by encoding pH-sensing motifs, based on the sequences of the pH-sensitive membrane-
active peptides GALA76 and pHLIP60, into the pH-insensitive, macromolecular pore-forming 
motif in MelP542. The designed peptides, named MelP5_Δ4 and MelP5_Δ6 (see Table 1), had 
four or six of the residues along the polar face of the putative amphipathic helix changed to 
glutamate or aspartate to impart pH sensitivity. Placement and spacing of the acidic residues were 
based on the helical spacings in GALA and pHLIP. We found that these rationally designed 
peptides gained pH sensitivity, as they permeabilized membranes only at pH < 5.0. But at the 
same time, they lost the ability to form macromolecular-sized pores23, demonstrating that the 
properties of MelP5, GALA, and pHLIP are only partially additive. 
Here, we approached the same goal with combinatorial chemistry and high-throughput 
screening, instead of rational design. Specifically we designed an iterative 18,432-member library 
using MelP5 as a template (Figure 1-1), creating a second- generation library that we screened 
orthogonally for peptides that release macromolecules from lipid vesicles at pH 5, but have little 
or no membrane-permeabilizing activity at pH 7. 
In the library, we varied the amino acids at nine positions (Figure 1-1). Unlike MelP5_Δ4 
and MelP5_Δ6, which had a fixed number and pattern of helically spaced acidic residues, the 
library contained peptides with 0−6 acidic residues distributed in all possible patterns along one 
face of the MelP5 amphipathic α helix. Our criteria for placement of acidic residues were as 
follows: (i) maximize the number of i to i+3, i to i+4, and i+ to i+7 α-helical spacings between 
acidic groups to maximize the electrostatic repulsion between them at neutral pH, and prevent 




Figure 1-1: Design of an iterative peptide library.  
The library is shown in helical wheel and space-filling representations. The library was 
based on the non pH-sensitive macromolecular pore-former MelP5 which is the sequence 
shown. Residue shape indicates type in the template sequence of MelP5, with diamonds 
representing hydrophobic residues and triangles representing polar residues, for example. 
Colors show residues that were varied in the library. Possible variations present in the 
library are shown at the bottom. Red positions could be the native residue, or aspartate or 
glutamate. In some cases, a fourth hydrophobic residue was also possible, as indicated. 
Blue residues are lysine in MelP5 and could be lysine or histidine in the library members. 
Position 17 could have the native hydrophobic isoleucine or a polar glutamine. The most 
important aspect of the library is in the incorporation of six possible protonatable acidic 




the acidic side chains will prevent binding and membrane insertion at pH 7 but allow it at pH 5. 
This pattern also enables library members to form amphipathic helices in which the protonation 
state of the acidic residues can make a significant contribution to helical propensity and 
membrane insertion; (ii) retain basic residues at positions 7 and 21 because we hypothesized that 
changing them to acidic residues in MelP5_Δ4 and MelP5_Δ623 may have altered the peptide 
function; (iii) retain overlap between the polar face of the MelP5 helix and the positions of the 
new acidic residues; (iv) reduce hydrophobicity as little as possible to maintain the propensity of 
the helix to partition into membranes; (v) avoid replacing any residues known to be critical to the 
activity of MelP5, specifically A10, P14, L16, and A2333; (vi) avoid replacing tryptophan 19 
because it is useful for concentration determination and as an optical probe of structure. With 
these criteria in mind, we elected to allow both glutamate and aspartate to appear at six positions: 
A4, V8, T11, G12, A15, and S18, giving the distribution shown in Figure 1-1. We also allowed 
the native residue in each of these positions. We allowed hydrophobic leucines to occur at 
positions A4, G11, and A18 and a somewhat hydrophobic alanine at T11 to modulate 
hydrophobicity. To potentially compliment the pH sensitivity of the acidic residues, we allowed 
the native lysines at positions 7 and 21 to also be histidine. Lysine will be cationic at all pH 
values below 8.5 whereas histidine will be cationic only below its pKa of ∼6.5. 
Previously, we showed that the presence or absence of polar residues at the boundary of 
the polar−nonpolar faces is a critical feature of MelP533. Specifically, the native T10 in the first 
generation library was replaced with alanine, which narrows the polar face substantially (Figure 
1-1). In the current library we preserved A10 on the N-terminal half of the peptide and allowed 
position 17, which defines the cutoff between the polar and nonpolar faces on the C-terminal half 
of the helix, to vary between hydrophobic isoleucine and polar glutamine. 
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There are 18,432 unique, 26-residue, MelP5 variants in the library. All library members 
share at least 17 residues of 26 in common with MelP5 such that the minimum identity is 73%. If 
we assume that D and E are equivalent, there are 64 different patterns of acidic residues in the 
library. If D and E are unique, there are 729 different patterns. From the library design in Figure 
1-1, we calculate the following abundance values: 2.8% of library members have six acidic 
residues (1 pattern of 64), 13.8% have five acidic residues (6 patterns), 28.5% have four acidic 
residues (14 patterns), 30.6% have three acidic residues (20 patterns), 18.1% have two acidic 
residues (14 patterns), 5.6% have one acidic residue (6 patterns), and 0.7% have zero acidic 
residues (1 pattern). 
The library was synthesized as a one-bead, one-peptide library using a well-established 
split-and-recombine approach33,47,48. Quality control for the synthesis was done using HPLC, 
MALDI mass spectrometry, and Edman degradation on peptide extracted from multiple 
individual beads. These methods showed that every bead examined contained predominantly a 
single pure sequence and that each sequence observed was, in fact, an expected member of the 
library. Each 0.3 mm polystyrene solid phase peptide synthesis bead releases about 0.5 nmol of 
one single sequence as described above. 
 
Orthogonal High-Throughput Screen Results for the pHD peptides 
The library was screened for peptides that simultaneously (i) cause little or no membrane 
permeabilization at pH 7, even for small-molecule reporters and high peptide concentrations, and 
(ii) cause macromolecule passage across bilayers at pH 5, at low peptide concentrations. Two 
different assays, described above, were used in tandem to achieve these aims. One was an assay 
for release of ANTS, a small molecule (Figure 1-2A), performed at pH 7. The second was an 




Figure 1-2: Leakage Assays 
Two different leakage assays are used to measure the pore-forming activity of the 
peptides and screen for the desired activities. (A) To evaluate leakage of small molecules 
we co-encapsulate ANTS, a small-molecule dye, and DPX, its obligate quencher, inside 
lipid vesicles82. Membrane destabilization results in release of ANTS and DPX and 
recovery of ANTS fluorescence. (B) To evaluate leakage of macromolecules, we used a 
recently published assay42 based on FRET detection. In this case, a 40 kDa dextran co-
labeled with biotin and the acceptor fluorophore, TAMRA, is encapsulated within 
vesicles. Streptavidin labeled with the donor fluorophore, AlexaFluor488, is on the 
outside of the vesicles. Upon macromolecular permeation, the TAMRA-biotin-dextran 
(TDB) can escape and form a complex with streptavidin, allowing FRET to occur. In our 
high-throughput screen, we measure leakage of ANTS/DPX at pH 7 and nominal P:L = 




two assays can be performed in parallel or in series in the same samples because there is no 
relevant overlap between ANTS fluorescence (ex/em 350/519 nm) and AF488 fluorescence 
(ex/em 488/505 nm). In the high-throughput screen described in Materials and Methods, the 
ANTS/DPX assay was conducted at a nominal peptide to lipid ratio of 1:200 at pH 7, and the 
dextran leakage assay was performed at nominal P:L = 1:800, at pH 5. Because the peptide 
release from individual beads varies, P:L could vary between individual wells by a factor of 2 or 
more. 
We screened 15,000 library members using the orthogonal high-throughput screen, 
covering about 80% of the library’s sequence space. In Figure 1-3 we show the ability of each 
screened peptide to cause small-molecule leakage at pH 7 and macromolecular leakage at pH 5. 
We present the results in the form of a scatterplot colored according to point density from yellow 
(highest density) to black (lowest density). Because there were vesicle batch-to-batch variations 
in the raw intensity values for each assay along the duration of the screen, we have plotted all 
values in Figure 1-3 as plate-by-plate Z-values; the points plotted are the number of standard 
deviations from the plate mean, on each axis. The density of points on the Y-axis is centered on 
zero because the distribution of dextran leakage has a symmetrical Gaussian shape. On the other 
hand, the distribution of points on the X-axis is offset from zero because ANTS leakage at pH 7 is 
asymmetric; many library members cause >80% leakage of ANTS at pH 7. 
Four points provide useful landmarks. The activities of 1 nmol and 4 nmol of the 
template MelP5 under the conditions of the screen are indicated in Figure 1-3, to compare with 
0.5 nmol of each library peptide. We also show values for blank wells with no peptide and for 
0.1% v/v Triton X100, which solubilizes all vesicles. A 1 nmol amount of MelP5 causes high 
small-molecule permeabilization and partial macromolecule release at all pH values. A 4 nmol 




Figure 1-3: Results of the screen.  
The serial, two part screen described in Figure 1-2 was used to assay 15,000 randomly 
selected library members. Vesicles were made from 100% POPC. The two activities for 
each of the 15 000 library members are shown as points on a temperature scale, where the 
point color is determined by point density, from yellow (most dense) to black (least 
dense). The results of each assay are shown as Z-values, or the difference of each point 
from the plate mean expressed as standard deviations. This approach normalizes for 
batch-to-batch variations in lipid vesicle intensities in the two assays. About 0.5 nmol of 
each library member was assayed. For comparison, we also show the values for 1 and 4 
nmol MelP5, for Triton-X-100 detergent, which solubilizes vesicles, and for buffer only. 
The center of the yellow area corresponds to ∼85% ANTS leakage and ∼30% dextran 
leakage. Most library members are similar to the template MelP5, but there are outliers in 
all four quadrants. The peptides we seek, with low ANTS leakage at pH 7 and P:L = 
1:200 and high TBD release at pH 5 and P:L = 1:800, are found in the upper left corner. 
Ten positive sequences, highlighted with red stars, were selected and sequenced using 
Edman degradation. Their sequences are shown in Table 1-1. 
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 release of both types of probes. The activities of most library members are centered on the 
yellow area in Figure 1-3; on average they have MelP5-like high leakage of ANTS at pH 7 and 
moderate leakage of dextran at pH 5. The center of the yellow area corresponds to ∼85% ANTS 
leakage and ∼30% dextran leakage. 
The activity we seek in this work is found in the peptides closest to the upper left corner 
of Figure 1-3. These peptides have low small-molecule permeabilization at pH 7 (P:L = 1:200) 
and high macromolecule permeabilization at pH 5 (P:L = 1:800). Ten library members, shown by 
red stars in Figure 1-3, were selected from within this region, and these peptides were sequenced 
using Edman degradation. Their sequences are shown in Table 1.1. Below we demonstrate that 
these selected peptides have exactly the properties we sought in the screen. Thus, our strategy 
was successful. 
Sequence Analysis of Positive pHD Peptides 
The positive sequences have many features in common with one another, demonstrating that we 
have identified a family of closely related sequences with a unique, shared activity. p-values were 
calculated against null hypotheses determined by the abundance of the particular residue, class, or 
motif in the library, using exact binomial statistics. Every positive peptide has five or six acidic 
residues out of six possible (p < 10−5). Positions 4 and 8 are acidic in all positives (p = 0.002 and 
0.007, respectively). In the remaining four positions that could have acidic groups, 11, 12, 15, and 
18, eight of the ten peptides have three acidic residues and one other nonacidic residue and two 
have six acidic residues. Of the nine possible i to i+3, i to i+4, and i to i+7 helical spacings of 
acidic groups available, the positive peptides have an average of 6.5 (range 5−9). The constancy 
of the acidic residue abundance supports the hypothesis, discussed earlier, that pH-triggered 





Table 1-1: Sequences of the pHD peptides. 
Top panel: Sequences of the natural bee venom pore-former melittin and its synthetically 
evolved gain-of-function variant, MelP542, which enables macromolecules to cross 
bilayers at low P:L. Using patterns from pH-sensitive membrane-active peptides, we 
previously designed two variants, MelP5_Δ4 and MelP5_Δ6, which exhibit pH-triggered 
membrane activity but do not induce macromolecular-sized poration23. Bottom panel: All 
of the positive peptides sequenced (see Figure 1-3). Peptides are named after the plate 
and well in which the positive bead was identified. For each peptide we list the number of 
acidic residues, and the number of helical spacings of i to i+3, i toi+4, and i to i+7 




formation of the amphipathic helix as it relates membrane binding (see measurements of helix 
content below). 
Among the 52 selected acidic residues, there was a strong preference for glutamate with 
36 glutamates selected compared to 16 aspartates (p = 0.007). The preference for E over D is 
even more striking in the first two and last two possible positions, where 26 of 33 acidic residues 
were glutamate (p =0.001). We do not currently know why this preference exists, but speculate 
that the longer side chain of glutamate enables more conformational flexibility of the side chains 
by which the electrostatic effects can be modulated, either between acidic groups or in the 
interactions of acidic residues with basic residues. When an acidic residue was possible but not 
selected, the selected residues included both native residues and the more hydrophobic residues 
possible, indicating no strong preference for the native residues at positions 11, 12, 15, and 18. 
Similarly, 9 lysines and 11 histidines were selected in positions 7 and 21, with no obvious 
preference or pattern. In fact, all possible patterns (KK, HH, HK, and KH) were observed in the 
10 positives. We conclude that the identity of the basic side chains and their charge state at pH 7 
are of little consequence to the function of these peptides. 
Finally, in position 17, where the native, hydrophobic isoleucine and the polar glutamine 
were possible, we found that the native residue was replaced with glutamine in 10 of 10 peptides 
(p = 0.002). The current lack of explicit structure− function relationships in these membrane-
active peptides makes it difficult to know exactly how this glutamine contributes to activity at this 
time, but we speculate that its hydrogen bonding capabilities may enable lateral interactions 
between peptides in the bilayer. We will investigate this and other structural hypotheses in the 
near future. 
It is interesting to compare the positive sequences selected from this library, which have 
the desired property of macromolecular poration at pH 5.5−5.8, to the rationally designed 
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sequences MelP5_Δ4 and MelP5_Δ6, which have a lower pKa for permeabilization and do not 
allow macro- molecules across membranes at any pH. The rational and selected peptides both had 
4−6 acidic residues with helical spacings. The acidic residues replacing V8, T11, and S18 are 
present in both families. The rationally designed peptides have 3 or 5 helical spacings between 
acidic residues, while the selected peptides have 5−9, but there is overlap. In any case, fewer 
helical spacings should theoretically lead to a higher pKa whereas the designed peptides actually 
had a lower pKa than the selected ones. We replaced one or both basic residues in the designed 
peptides whereas these positions only contained basic residues in the library because we 
hypothesized that favorable electrostatic interactions with the basic residues could abrogate acidic 
repulsions in the library-selected peptides. Furthermore, the designed peptides always had 
isoleucine in position 17, while the selected peptides always had glutamine at position 17. 
Isoleucine was available at position 17 in the library, but was never selected. While we can list 
the differences between our screening successes and our design failures, it is currently not 
possible to explain or predict these behaviors in molecular terms, effectively demonstrating the 
power of synthetic molecular evolution. We hope that structural and computational scientists will 
endeavor to explore these mechanistic questions more deeply in the near future.  
 
Verification of Positive pHD Peptides 
Since the selected peptides are very similar to each other, we chose to synthesize and purify a 
subset of them for detailed validation. Tested peptides included four representative sequences 
with five acidic residues, pHD24, pHD34, pHD108, and pHD118 as well as pHD15, one of the 
two with six acidic residues. Because we are interested in pH-triggered macromolecule release at 
low pH, we validated the positive peptides with both the ANTS assay and the macromolecular 
release assay using 40 kDa dextran and 53 kDa streptavidin, described above.  
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Dextran leakage was measured as functions of peptide concentration and pH using 
vesicles made from phosphatidylcholine lipids. The leakage of 40 kDa dextran from lipid vesicles 
at P:L = 1:200 as a function of pH is shown for these peptides in Figure 1-4A. At this 
concentration, all of the selected peptides cause 100% dextran release at pH 5 and no leakage at 
pH 7, as desired. Activity occurs only as pH is decreased into the range of pH 6 to 5.5. The 
apparent pKa values for the five peptides are similar, ranging from 5.5 to 5.8, with pHD15 having 
the lowest apparent pKa value, consistent with it having one more acidic residue. Consistent with 
this result, and with the screen, we also observe <5% ANTS leakage at pH 7 (P:L = 1:200) and 
∼100% leakage at pH 5 (not shown). We note that the macromolecule leakage activity measured 
in Figure 1-4 is unique and remarkable, as there are no other peptides known, except for MelP542, 
that have been shown to release macromolecules from lipid vesicles at such low P:L ratios under 
any conditions. These synthetically evolved peptides have a pH-triggered version of this activity 
and release macromolecules at pH 5 even better than MelP5 does at any pH.  
Dextran release at pH 5 and pH 7 as functions of peptide concentration (expressed as 
peptide to lipid ratio, P:L) is shown in Figure 1-4B, for pHD 15, pHD 24, and pHD 108. The 
dashed lines show that there is no activity at pH 7, as desired, even at peptide to lipid ratios as 
high as 1:50. However, at pH 5 the selected peptides induce substantial macromolecule leakage 
with 50% leakage activity at peptide to lipid ratios of 1:900 for pHD108 and 1:750 for pHD24. 
pHD15, which has six acidic, is the least active of the positives tested, with 50% release at P:L = 
1:600. While MelP5 has been shown to release a 10 000 Da dextran at similar concentrations,37 it 
releases the 40,000 Da dextran used in this work at ~P:L = 1:100. Taken together, these results 
show that we have successfully identified peptides that are significantly more active than the 




Figure 1-4: Macromolecular Leakage. 
(A) Macromolecule leakage versus pH. A representative set of positive peptides 
from Table 1 were synthesized and assessed for their ability to promote leakage of a 
40 000 Da TAMRA-biotin-dextran (Figure 1-2B) at P:L = 1:200 and 1 mM POPC 
vesicles. Changes in pH lead to sharp transition in macromolecular poration. The 
apparent pKa values from the curve midpoints range from 5.5 to 5.8. (B) Macromolecule 
leakage versus concentration. The peptides assessed for their ability to promote leakage 
of a 40 000 Da TAMRA-biotin-dextran (Figure 1-2B) at pH 5 and pH 7. The peptides 
exhibit no activity at pH 7, as desired, even at peptide to lipid ratios as high as 1:50 
(dashed lines). At pH 5 all peptides potently cause TBD release with curve midpoints that 





We also studied the peptide secondary structure in the presence of vesicles as a function 
of pH by circular dichroism (CD) spectroscopy. Example CD spectra for pHD108 at P:L = 1:200 
(Figure 1-5A) show a pH-triggered transition from random coil to α-helical structure with an 
effective pKa around 5.5. Finally, we measured tryptophan fluorescence as a function of pH at 
1:200 which provides a measure of membrane partitioning. Like the CD spectra, example 
fluorescence spectra for pHD108 (Figure 1-5B) also show a sharp transition from lower intensity 
emission at 360 nm to higher intensity and 340 nm emission maximum, consistent with a 
transition from weak to strong membrane partitioning over the expected pH range of 5−6. In 
Figure 1-6 we directly compare the pH dependence of macromolecule leakage, helicity, and 
tryptophan fluorescence for three peptides at P:L = 1:200, and show that they are very similar, 
with pK of 5.5−5.8, consistent with our hypothesis that leakage, helicity, and binding are coupled 
for macromolecule release.  
Macromolecule Leakage Screen for the Macrolittins 
The library design, shown in Fig. 1-7C, uses MelP5 as a template and includes six sites in which 
protonatable aspartate or glutamate residues, as well as the original residue, were possible. In the 
screen, modified from one described previously22, two assays were performed in series. First, 
leakage of the small molecule fluorophore ANTS and its quencher DPX, was measured at pH 7 
and at P:L of 1:200. Next, additional vesicles containing entrapped TAMRA-biotin-dextran 40 
kDa (TBD) and external AlexaFluor488-streptavidin were added to bring P:L to 1:400, a 
relatively low P:L value. Leakage of TBD was measured by assessing FRET between TBD and 
the labelled streptavidin after 1 hour of incubation. 
We screened 3200 library members, and the distribution of Z-values (standard deviations 
from individual plate averages) for the two assays are shown in Fig. 1-7A. Controls included no  
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Figure 1-5: Example binding and folding data.  
(A) Circular dichroism spectra of pHD108 versus pH at P:L = 1:200 in 1 mM POPC 
vesicles. Separate samples are made at each pH and equilibrated for 30 min prior to the 
measurement. The spectra show a structural transition from random coil at pH 7 to 
classical α-helix at pH 5.75. (B) Tryptophan fluorescence spectra of pHD108 at P:L = 
1:200 in 1 mM POPC vesicles. Separate samples are made at each pH and equilibrated 
for 30 min prior to the measurement. The spectra show a transition from a more polar, 
water-exposed environment to a less polar, buried environment consistent with peptide 





Figure 1-6: Coupling of binding, 
structure, and activity.  
For three pHD peptides we plot changes in 
TBD leakage, changes in α-helicity from 
CD, and changes in tryptophan 
fluorescence as pH is varied. All 
measurements are at P:L = 1:200. Curves 
represent the global fit for each peptide of a 
cooperative transition using all three data 
sets. There is little or no detectable 
difference between the pKa values for 
leakage, structure, and binding, consistent 




Figure 1-7: Selection of macrolittins by synthetic molecular evolution.  
(A) The results of the screen. Z-values (library member – plate mean)/ (plate standard 
deviation) for each library member are shown for the small molecule screen at pH 7 and 
for the macromolecule screen at pH 7. The macrolittins, red stars, were selected for 
simultaneous potent pore-forming activity in both screens. (B) Histogram of 
macromolecule leakage values for the library members screened at P:L = 1:400 and pH 7. 
The macrolittins are in the most active 2% of the peptides screened. (C) Table of peptide 
sequences. The sequence of the parent MelP5 and the MelP5-derived library is shown. 
The macrolittin sequences and pHD peptide sequences selected during the screens are 
also shown. Bold residues were varied. Acidic residues are red, basic residues are blue, 
hydrophobic residues are green, and polar residues are orange. (D) Helical Wheel 
projections of the peptides discussed in this work. Acidic (red), basic (blue), and polar 
(yellow) residues are shown to highlight amphipathicity. Varied residues in the library 
are indicated by colored outlines, where red signifies acidic residues were included and 
blue signifies lysine and histidine were possible.  
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peptide, Triton-X100 detergent for 100% release, and 4 nmol which causes near total 
macromolecule release. For comparison, there was about 0.5 nmol of each library member 
present in the screen. The MelP5 controls correspond to P:L of 1:25 in the small molecule and 
P:L of 1:50 in the macromolecule screen. This amount of MelP5 releases nearly 100% of the 
small molecules ANTS and DPX and the dextran. 
The majority of library members screened cause significant small molecule leakage, and 
some macromolecule leakage. Here, we are interested in the outliers that cause significant 
macromolecule release. Therefore, positive peptides were selected from the area around the upper 
right hand quadrant of the plot. This quadrant represents simultaneous high small molecule 
leakage at pH 7 and high macromolecule leakage at pH 7. The sequenced library members are 
shown as red stars. They are found in the upper 2 percentile of the screened sequences on the 
macromolecular leakage axis (Fig. 1-7B). Thus, these peptides are gain-of-function daughter 
sequences of MelP5; they form macromolecule size pores in PC bilayers at pH 7 and at low 
peptide concentration. The screen suggested that the selected positives are much more potent than 
the parent peptide MelP5 at macromolecular poration, because ~0.5 nmol of these library 
members (P:L = 1:400) and as much as the 4 nmol MelP5 control (P:L 1:50). 
Sequence Analysis of the Macrolittins 
The sequences of five selected peptides, which we named “macrolittins” are shown in Fig. 1-7C 
along with the sequences of MelP5, the MelP5-based library, and the pHD peptides, for 
comparison. In Fig. 1-7D we show helical wheel representations of the idealized helical surfaces 
of the parent MelP5, and representative members of the sequence families. The macrolittins have 
a sequence motif that always contains three acidic residues, either glutamic or aspartic acid out of 
six possible acidic residues in the library. The probability of this occurring by chance five times 
(p) is 0.013. The acidic residues at the fourth and eighth positions are highly conserved (9/10 in 
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total) in the five macrolittins. They are also conserved in the ten pHD peptides (20/20 total). The 
macrolittins sometimes have acidic residues in position 11 (3/5 peptides), position 15 (2/5), 
infrequently in position 12 (1/5) and position 18 (0/5), averaging about 1.0 acidic residues per 
peptide in those four positions. In comparison, each pHD peptide has either 3 or 4 acidic residues 
in those four positions, averaging 3.2 acidic residues per sequence in those four positions. More 
specifically, while positions 12 and 18 are acidic in the pHD peptides in 17 out of 20 chances, 
they are rarely acidic in the macrolittins (1/10) giving a probability of < 0.0001 for this to have 
arisen by chance. 
For the basic residues in positions 8 and 21 of the macrolittins, lysine was selected over 
histidine, 9 times in 10 chances (p=0.01). This demonstrates a strong preference for lysine in the 
macrolittins that does not exist in the pHD peptides. Slightly more than half (11/20) of the 
possible basic residues in the pHD peptides were histidine instead of lysine, indicating that there 
is no preference. We note that both histidine and lysine are charged at pH < 5.5 where the pHD 
peptides are active, while only lysine is charged at pH 7 where the macrolittins are active. 
Macromolecule Leakage of the macrolittins 
To fully characterize the sequences identified in the screen, we synthesized three 
representative macrolittins, 70, 159 and 204 (Fig. 1-7) and measured their ability to permeabilize 
lipid vesicles made from POPC to a 40 kDa dextran as a function of peptide concentration. The 
leakage activity curves at pH 7 are shown in Fig. 1-8A. Macrolittins release TAMRA-biotin 
dextran (40 kDa) with a leakage inducing concentration of 50% effect (LIC50) of P:L ≤ 1:800. 
This is remarkably potent activity for macromolecule release, matched only by the pHD peptides 
at pH 5 (Fig. 1-8B). While MelP5 releases a 10 kDa dextran at similar LIC50,42 its ability to 




Figure 1-8: Macrolittin-induced leakage of a 40 kDa dextran from POPC vesicles.  
Vesicles with entrapped TAMRA-biotin-dextran 40 kDa (TBD) were incubated with serial 
dilutions of peptide in the presence of Alexafluor488-streptavidin (AF488-SA) for 1 h. FRET 
between TBD and AF488-SA was measured, followed by disruption with Triton-X100 to 
determine the FRET for complete leakage. (A) Experiments at pH 7, where the pHD peptide 




active pHD peptides, at pH 5, release 40 kDa dextran with LIC50 values of P:L=1:80022, similar to 
the macrolittins at pH 7. 
We also measured macrolittin-induced dextran leakage at pH 5 (Fig. 1-8B) to directly 
compare the macrolittins to the pHD peptides under identical conditions. Surprisingly, the two 
families have opposite pH dependences. Unlike the pHD peptides which gain activity at pH 5, the 
macrolittins are somewhat less potent at pH 5 than they are at pH 7, with LIC50 values between 
1:150 and 1:400. However, even at pH 5, the macrolittins are more potent than MelP5. The 
activity of MelP5 is similar at both pH values as reported previously22. 
Circular Dichroism and Tryptophan Fluorescence for the Macrolittins 
To assess the secondary structure of the macrolittins, we measured their circular 
dichroism spectra, at pH 7 and pH 5, in buffer with and without lipid vesicles. The control peptide 
MelP5 is random coil in buffer and becomes highly helical only upon membrane binding (Fig. 1-
9). Surprisingly, the macrolittins are highly helical in buffer at pH 7 (Fig. 1-9A), and also at pH 5 
(Fig, 1-9B), even in the absence of lipid vesicles. This unexpected finding suggests that they 
readily self-assemble into stable helical multimers in buffer perhaps like the melittin tetramers 
that form under some conditions83. In the presence of POPC vesicles, the macrolittins retain their 
well-organized alpha helical secondary structure, while the control peptide MelP5 shows a sharp 
transition to alpha helix only upon binding to vesicles. 
We used the fluorescence of the single tryptophan at position 19 of the peptides, to 
further assess their structure in buffer and in membranes. The tryptophan in MelP5, which is 
random coil and monomeric in buffer, has an emission maximum of 349 nm at pH 7 and at pH 5 
as expected for a water-exposed tryptophan in a monomeric peptide (Fig. 1-10). On the other 
hand, the macrolittins in buffer have tryptophan emission maxima from 319-333 nm, significantly 




Figure 1-9: Solution circular dichroism spectra of macrolittins and MelP5 at 25 uM.  
Measurements were made before addition (dashed lines) and after addition (solid lines) of 





Figure 1-10: Tryptophan fluorescence spectra of the macrolittins and MelP5. 
Spectra were measured for 5  M peptide before addition (dashed lines) and after addition 
(solid lines) of 1 mM POPC vesicles. Excitation was at 280 nm. Emission spectra are 
normalized to the maximum intensity in buffer.  
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with our conclusion that the macrolittins form helical multimers in buffer, as multimer formation 
would bury the Trp residue in a less polar environment. In the presence of POPC vesicles, MelP5 
and the macrolittins have very similar tryptophan emission maxima of 320-330 nm, signifying a 
similar environment in the membrane. These emission maxima are in the expected range for a 
tryptophan that is membrane inserted45 as we have reported for MelP533 and the pHD peptides at 
pH 5 in bilayers22. 
Oriented circular dichroism spectroscopy of the Macrolittins 
To determine the orientation of the macrolittin helices in bilayers, we used macrolittin159 
as a representative of the family, and subjected it to oriented circular dichroism (OCD). Samples 
for OCD were hydrated stacked multilayers containing 5 mol% peptide. The experimental OCD 
spectra are shown in Fig. 1-11, and can be compared to the theoretical OCD spectra shown as a 
function of fraction of peptide inserted in a membrane spanning orientation84. Comparison of the 
positions and ratios of the experimental macrolittin159 OCD spectral peaks to the theoretical 
peaks suggested that macrolittin159 is a membrane-spanning helix at pH 7. We estimate an 
inserted fraction of at least 80%. Previously, we showed that MelP5 is also a membrane-spanning 
helix under these conditions33. 
Discussion 
Several thousand membrane destabilizing peptides, including antimicrobial peptides and other 
classes of pore-forming peptides, have been described and investigated over the past decades81,85–
88. Many of these peptides are cationic and destabilize anionic bilayers in a manner driven by 
strong electrostatic interactions. Efficient permeabilization of zwitterionic phosphatidylcholine 
(PC) bilayers at low P:L (≤1:100) is uncommon, and efficient release of macromolecules from PC 
vesicles at low P:L ratios was essentially unknown until we reported the discovery of a novel 




Figure 1-11: Oriented Circular Dichroism.  
(A) OCD spectra are shown for macrolittin159 and for MelP5 in comparison in stacked, 
oriented POPC multibilayers on a quartz substrate hydrated with water through the vapor 
phase. Spectra are the average of eight individual spectra collected at rotations around the 
beam axis. The lipid only spectra have been subtracted. (B) Basis theoretical OCD 
spectra, (top and bottom curve) and linear combinations for parallel and perpendicular 
helices calculated as described previously84. The four intermediate curves are for 
increments of perpendicular helix increasing by 20% per step.  
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macromolecules through membranes, even at very low peptide-to-lipid ratios (P:L ≤ 1:500 when 
using 10,000 Da dextran as a probe) where detergent-like vesicle solubilization is unlikely36,42. 
Here, we used MelP5 as a template for an iterative peptide library that we designed and screened 
to select peptides that cause macromolecular permeabilization of a 40000 Da dextran at low P:L, 
like MelP5, but in a pH-dependent manner. The peptides that were identified are remarkably 
potent, macromolecular sized pore-formers at pH 5, while having little or no membrane activity at 
all at pH 7. Thus, we succeeded in “evolving” MelP5 for gain of function. All of the selected 
peptides possess exquisite pH sensitivities, with activities transitioning from ∼0 to ∼100% over 
one pH unit, centered on apparent pKa values of 5.5 to 5.8. This success in achieving a goal that 
we previously failed to achieve using a completely rational design approach23 highlights the 
power of synthetic molecular evolution.  
Mechanism of Action of the pHD peptides 
All 10 of the positive peptides identified in the library have five or six acidic residues out of the 
six possible, despite the fact that only 17% of library members have five or six acidic residues. 
The peptide with six charges that we tested is somewhat less potent and has a lower pKa than the 
peptides with five charges (Figure 1-4B), suggesting that five negative charges arranged with 
helical spacing on an amphipathic helix are optimal for the observed pH-triggered activity. The 
fact that we observed various patterns of five acidic residues in the selected positives indicates 
that the pH sensitivity is due to the physical chemistry of folding and membrane binding. Yet, the 
specific preference of glutamate compared to aspartate, the overabundance of acidic residues is 
several positions, and the 100% conservation of glutamine at position 17 suggests that sequence-
specific interaction may also play a role in this activity. 
According to the Henderson−Hasselbalch equation, an equilibrium that simply reflects 
protonation of glutamate or aspartate should transition from 10% to 90% complete over two pH 
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units and 1% to 99% over four pH units. However, we observe transitions in dextran leakage, 
secondary structure and binding by the pHD peptides from near 0% to near 100% over one pH 
unit (Figure 1-6), indicative of highly cooperative behavior. Furthermore, the apparent pKa 
values that we measure for the selected peptides range from 5.5 to 5.8, much higher than the pKa 
of ∼3.5 to 4.0 expected for the free side chains for Glu or Asp. We hypothesize that the tight 
coupling between membrane partitioning, α-helix formation, and electrostatic repulsion between 
acidic side chains drives both the upward shift in pKa, relative to that of the free side chains, and 
the unexpectedly sharp transition. Potentially favorable electrostatic interactions between the 
basic lysine and histidine residues, and some of the acidic side chains may also contribute to the 
pH sensitivity.  
To estimate the protonation state of the peptide, we used the Membrane Protein Explorer 
(MPEx)89 to predict free energies of membrane partitioning of the pHD peptides compared to 
MelP5. Assuming that bound peptides are 75% α-helix33 (Figure 1-5A), protonation of at least 
four or five of the acidic side chains in the pHD peptides would be required for strong membrane 
partitioning that we observed at pH 5. Thus, we hypothesize that most of the acidic side chains in 
the pHD peptides are cooperatively protonated with an apparent pKa of 5.5−5.8.  
Implications for Peptide Design and Applications 
In previous work, we attempted to engineer pH sensitivity into the unique macromolecular 
poration activity of MelP5, but failed. Here we achieved the goal of pH-triggered macromolecular 
poration using a fundamentally different approach: synthetic molecular evolution, which is 
accomplished with orthogonal screening of a rationally designed, iterative, combinatorial peptide 
library. Despite being able to list similarities and differences between the rationally designed and 
molecularly evolved peptides, we are not able to identify obvious logical flaws in the rational 
design approach based on any molecular principle. Specific design principles are not yet apparent 
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from sequence comparison alone. Given the lack of complete understanding of structure−function 
relations for membrane-active peptides in general, our work shows that synthetic molecular 
evolution is a powerful, and necessary, method to drive the discovery of novel peptides with 
specific membrane activities.  
The peptides we have selected cause pH-triggered macromolecular poration, a property 
that could potentially be exploited in multiple ways. For example, there are applications in 
medicine where acidic environmental pH could be used to trigger the activity of the new peptides. 
One example is the acidic environment around solid tumors62 where tumor selective cytolytic 
activity could be triggered. A second example are acidified organelles, such as endosomes and 
lysosomes14,90,91,17,49−51 where selective cargo delivery into the cytosol could be enabled by 
pH-induced macromolecular poration. The work described here opens new doors to exploring 
such applications using peptides with activities that are triggered by a physiologically relevant 
decrease in pH.  
Macrolittin Discussion 
Here we have also described the macrolittins, a family of peptides that release 
macromolecules from lipid bilayers made from zwitterionic PC lipids at very low peptide 
concentration and at neutral pH. Macrolittins readily enable the passage of a 40,000 Da dextran, a 
macromolecule with 4.5 nm hydrodynamic radius through lipid bilayers. Macromolecule release 
from liposomes is measurable at P:L as low as 1:5000 (20 peptides per vesicle) and reaches 50% 
at P:L as low as 1:1000, or 100 peptides per vesicle. Except for the pHD peptides at low pH (Fig. 
1-8B), such potent macromolecular poration by peptides in PC bilayers is unprecedented in the 
literature. 
In the MelP5-based library from which both the macrolittins and the pHD peptides were 
selected, six positions had the possibility of containing an acidic aspartate or glutamate residue, or 
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the native residue or, in some cases, another nonpolar residue (Fig. 1-7). The selected macrolittins 
share a common, variable motif, always with three acidic amino acids per peptide, compared to 
five or six in all pHD peptides. In Fig. 1-7D, we show the helical wheels of MelP5, the library, 
representative macrolittins, and representative pHD peptides. We note that these helical wheels 
may not be precisely correct because the Gly-Leu-Pro segment at residues 12-14 may be poorly 
structured and may lead to N- and C-terminal helices that are somewhat independent of each 
other. Nonetheless, the helical wheels show that the library template sequence of MelP5 is highly 
amphipathic with a narrow polar face width. The library contains protonatable residues spread 
across a face that is much wider than the polar face of MelP5 and could potentially increase the 
polar face angle to almost 180°. While the polar face of the pHD peptides encompasses the 
largest widths that are encoded in the library, some of the acidic residues may be protonated at pH 
5 where the peptides are active. The macrolittins show a narrower polar face with acidic residues 
mostly in positions 4,8 and 11 or 15, which comprise the center or the polar face. Residues 12 or 
18, which are the outside-most two residues on the acidic face, are rarely found to be acidic in the 
macrolittins (1/10), while they are acidic most of the time (17/20) in the pHD peptides.  
The fact that two acidic residues at positions 4 and 8 are nearly 100% conserved in the 
five macrolittins (and also in the ten pHD peptides) may indicate that they are critical for the 
function that we observe for both families of peptides. The core of the polar face may be 
important for the structure that enables macromolecular poration. If so, the outermost residues of 
the wide polar face of the pHD peptides may be important for pH sensitivity. The conserved 
anionic residues at residues 4 and 8 are found on the same face of the N-terminal half of the helix. 
They are at about a 90° angle on the helical wheel from either of the two positive residues, 
residues 7 and 21. The fact that we found lysine over histidine in these positions in 9/10 chances 
indicates that having a positive charge at pH 7 is important for macrolittin function. We speculate 
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that parallel macrolittin helices have lateral electrostatic interactions between the conserved 
acidic groups and the basic amino acid at position 7. Such a stabilized structure would create an 
amphipathic surface that could participate in a large pore. Antiparallel helices that are 
electrostatically stabilized by interactions between the N-terminal acidic residues and the basic 
residue at position 21 are also possible, however the surface formed would be less amphipathic 
and thus seems less likely. 
The ability to fold into an amphipathic  -helix in membranes is a common property for all 
of the generations of peptides discussed here, and for many other membrane permeabilizing 
peptides92. The original natural parent peptide, melittin, forms an amphipathic helix in 
membranes that lies mostly parallel to the membrane surface and creates transient pores at 
moderate concentrations36,93–95. The synthetically evolved daughter sequence MelP5 has a more 
ideally amphipathic structure than melittin. It exists in a stable transmembrane configuration in 
PC bilayers and forms equilibrium pores33 that release macromolecules42. This behavior is 
consistent with the observation reported here that the macrolittins also have a transmembrane 
orientation. Transmembrane orientation is likely a critical structural requirement for 
macromolecular poration33. 
We do not yet know the pore structure, but we can narrow the possibilities by considering 
minimal possible geometries. An extruded unilamellar vesicle is nominally 50 nm in radius, has 
about 100,000 lipids and has a surface area of ~ 3x104 nm^2. A dextran of 40 kDa has a 
hydrodynamic radius of ~4.5 nm meaning that a “pore” of at least 80 nm^2 (5 nm radius, 1/300 of 
the vesicle surface area) would be minimally required to pass it. If we consider a classical barrel-
stave pore, in which the peptides are laterally close-packed, the pore would have a circumference 
of at least 30 nm, which would require ≥ 30 peptides to line it. Thus, a lipid vesicle can have only 
a few pores at P:L ~ 1:1000 (100 peptides per vesicle), where activity is high. 
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With such large pathways across the bilayer, it may be more fruitful to consider a 
structural model in which these amphipathic peptides drive bilayer thinning and stabilize exposed 
bilayer edges by reducing line tension at low concentration as other amphipathic peptides, 
proteins, polymers and detergents do at higher concentration96–99. In this scenario, individual 
peptides are not in direct contact with each other, but instead cooperatively alter lipid thickness 
and curvature to stabilize an exposed bilayer edge in a so-called toroidal pore geometry100–102. In 
this architecture, electrostatic stabilization remains possible because such interactions have a long 
range. Fewer peptides could be needed to stabilize such a toroidal “pore”. The critical 
interactions, in this case, would be curvature-dependent interactions between peptides and the 
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Abstract 
Using synthetic molecular evolution, we previously discovered a family of peptides that cause 
macromolecular poration in synthetic membranes at low peptide concentration, in a way that is 
triggered by acidic pH. To understand the mechanism of action of these “pHD peptides”, here we 
systematically explored structure-function relationships through measurements of the effect of pH 
and peptide concentration on membrane binding, peptide structure, and the formation of 
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macromolecular-sized pores in membranes. Functional assays demonstrate the peptide-induced 
appearance of large pores in bilayers. Pore formation has a very steep pH dependence, and is also 
dependent on peptide concentration. In vesicles, 50% leakage of 40 kDa dextrans occurs at 1 
bound peptide per 1,300 lipids, or only 75 peptides per vesicle, an observation that holds true 
across a wide range of acidic pH values. The major role of pH is to regulate the amount of peptide 
bound per vesicle. The physical chemistry and sequence of the pHD peptides affects their potency 
and pH dependence, and therefore the sequence-structure-function relationships described here 
can be used for future design and optimization of membrane permeabilizing peptides for specific 
applications.  
Introduction 
Membrane active, pH-sensitive peptides can be utilized for delivering cargo to cells through 
endosomes78,103,104, or for new therapies that target cancer cells60,72,77, among other applications. 
Although the mechanism of action of several such pH-sensitive peptides have been studied, the 
peptides previously investigated either insert as monomers without pore formation (i.e. pHLIP), 
or form only small pores in membranes (e.g. GALA)75,76. Large pores are needed for most 
applications. The mechanism of action of pH-sensitive peptides that form large, macromolecule-
sized pores will likely involve additional factors such as cooperativity and peptide-peptide 
interactions. By rationally designing  an iterative peptide library based on a pH-insensitive pore-
forming peptide, MelP523,42, and using a high-throughput functional screen, we have previously 
discovered a family of peptides that cause macromolecular poration in synthetic membranes at 
low concentration, in a way that is triggered by acidic pH22. These peptides, which we named the 
pH-dependent Delivery (pHD) peptides, are unprecedented in their ability to cause highly 
efficient, pH-triggered leakage of large molecules through synthetic membranes. At pH 7 or 
above, the members of this synthetically evolved family of sequences are essentially inactive; 
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they induce little release of small or large molecules from lipid bilayer vesicles. Yet, at pH ≤ 6, 
they bind to membranes, fold into -helices, and enable efficient release of macromolecules at 
very low peptide concentration. 
To understand the mechanism of action of the pHD peptides, here we asked how peptide 
density on membrane surfaces and cooperativity between peptides promote macromolecule-sized 
pore-formation. Furthermore, we asked how pH regulates these processes.  To answer these 
questions, we examined the structure of the pores formed, and we systematically explored 
structure-function relationships through measurements of the effect of pH and peptide 
concentration on membrane binding, peptide structure, and the formation of large pores by the 
pHD peptides in fluid phase phosphatidylcholine (PC) membranes.  
Results 
Peptides Selected for Study 
Here, we selected three pHD peptides for detailed characterization. The peptides pHD24 
(GIGDVLHELAADLPELQEWIHAAQQL) and pHD108 
(GIGEVLHELAEGLPELQEWIHAAQQL) were selected because they are canonical sequences, 
with 5 acidic residues like most of the active sequences identified. These two peptides had 
similarly potent activity, and similar pH50 values in our preliminary studies22. pHD24 has 3 
aspartate residues and two glutamates, the more common acidic residue found across the family, 
while pHD108 has 5 glutamates. The peptide pHD15 
(GIGEVLHELADDLPDLQEWIHAAQQL) is an outlier which has 6 acidic residues. Its potency 
is somewhat lower, and it becomes active at a somewhat lower pH than the others. We include it 
here to enable characterization across a range of potencies and pH dependences. 
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Macromolecular poration by the pHD peptides 
Using the same fluorescence-based assay we developed for the screen in which we discovered the 
pHD peptides22, we characterized the ability of pHD15, pHD24, and pHD108 to form large pores 
in vesicles as a function of both pH and peptide concentration. Results from these assays are 
shown in Figure 2-1. Figure 2-1A shows a schematic of the assay. The entrapped probe used to 
detect macromolecule leakage was a 40,000 Da dextran labelled with the dye TAMRA 
(fluorescence acceptor) and with biotin (called “TBD” for TAMRA-biotin-dextran). The external 
solution contained streptavidin labelled with Alexafluor488 (fluorescence donor).  In this assay, 
leakage of encapsulated TBD leads to streptavidin-TBD complex formation and quenching of 
Alexafluor488 due to FRET23,42. The hydrodynamic radius of dextran is about 4.5 nm105, and 
therefore a pore with a radius of at least 45 Å is required to form in the bilayer, for dextran 
leakage to occur. In Figure 2-1B, we show the kinetics of TBD leakage. Upon addition of peptide 
to solution of vesicles at pH 5, the donor fluorescence drops steeply and reaches a plateau. 
Leakage is rapid, with greater than 90% leakage occurring over 10 minutes. In Figure 2-1C we 
show the fractional leakage of TBD, measured at 60 minutes, as a function of peptide-to-lipid 
ratio (P:L) at pH 5. pHD24 and pHD108 are very potent at pH 5, with substantial activity 
observed at concentrations as low as 1 peptide per 1000 lipids, and ≥95% activity at P:L = 1:200.  
pHD15 is less active, with ≥95% activity occurring at about P:L = 1:100. MelP5, the parent 
peptide used for library design, is less active than pHD15 with ≥ 95% activity at P:L > 1:50. No 
leakage is observed at pH 7 for any of the pHD peptides, even at the highest concentrations 
measured. In Figures 2-1D-F, we show the leakage as a function of pH for pHD15, pHD24, and 
pHD108. At the lowest concentrations, little or no leakage is observed at any pH. At the highest 
concentrations, leakage sharply transitions to 100% with decreasing pH. Under these conditions, 




Figure 2-1: Macromolecular leakage assay.  
(A) Schematic of the assay. Peptides were incubated with streptavidin-AlexaFluor488 
and POPC vesicles containing TAMRA-biotin-dextran (TBD) for 1 h. Upon peptide-
mediated macromolecular poration, the 40 kDa dextran can leak out of the vesicles and 
form a complex with streptavidin, leading to FRET. (B) Time course of streptavidin-
AlexaFluor488 (donor) intensity upon TBD vesicle permeabilization. At about t = 5 min, 
pHD108 (P:L = 1:100) was added to a solution of 1 mM POPC at pH 6. After 1 h, Triton 
X100 was added for the 100% leakage fluorescence value. (C) Extent of dextran leakage 
as a function of concentration at pH 5 and 7. At pH 5, the pHD peptides are more potent 
than MelP5. At pH 7, the pHD peptides are not active, even at the highest concentrations 
measured. (D–F) Dextran leakage as a function of pH and P:L for pHD15 (D), pHD24 




indicates that  the acidic residues protonate and deprotonate cooperatively106. Interestingly, we 
observe a large increase in pH50 as peptide concentration is increased. Peptides pHD24 and 
pHD108 experience a  shift of about one pH unit when the peptide concentration is increased 
from P:L of 1:500 to 1:50. For pHD15, the shift is somewhat smaller at P:L where it can be 
compared.   
Small molecule release in response to the pHD peptides 
To determine if the pHD peptides form small pores at low peptide concentrations, we measured 
pore formation with an ANTS/DPX leakage assay, which detects the leakage of ~0.4 kDa 
ANTS107. Results from these assays are shown in Figure 2-2. Vesicles containing co-encapsulated 
fluorophore (ANTS) and quencher (DPX) were incubated with peptide for 1 hour. Figure 2-2A 
shows a schematic of the leakage assay. Crowding of ANTS and DPX within the vesicles 
quenches ANTS fluorescence. Pore-formation results in ANTS/DPX release and a concomitant 
increase in ANTS fluorescence. In Figure 2-2B, we show the kinetics of leakage. Upon addition 
of peptide, ANTS fluorescence increases sharply, then reaches a plateau. Release of ANTS and 
DPX is rapid, and very similar to TBD leakage, with greater than 90% leakage occurring over 10 
minutes. In Figure 2-2C we show fractional leakage of ANTS and DPX, measured at 60 minutes, 
as a function of peptide-to-lipid ratio. The peptides are very potent at pH 5, with substantial 
activity observed at concentrations as low as P:L = 1:1000 , and ≥95% activity at P:L = 1:200. 
Small molecule release is more potent than macromolecule release (Figure 2-1). In small 
molecule leakage, as with macromolecule leakage, pHD15 is less active than pHD24 and 
pHD108, and MelP5 is less active than pHD15, but the differences are smaller than for 




Figure 2-2: ANTS/DPX leakage assay.  
(A) Schematic of the assay. Peptides were incubated with POPC vesicles with 
encapsulated ANTS (fluorophore) and DPX (quencher) for 1 h. Upon pore formation, the 
dilution of ANTS and DPX results in an increase in ANTS fluorescence. (B) Time course 
of ANTS leakage by pHD108 at pH 5. ANTS fluorescence was monitored on a 
fluorimeter (ex/em = 350/519 nm). At about t = 3 min, peptide was added to a cuvette 
with 1 mM POPC vesicles for a final P:L of 1:100. After 1 h, Triton X100 was added to 
obtain the 100% leakage fluorescence value. (C) Leakage as a function of P:L. At pH 5, 
the pHD peptides are more potent than MelP5. At pH 7, (dashed lines) the peptides do 
not cause much leakage, even at the highest concentrations measured. (D–F) Leakage as 
a function of pH for pHD15 (D), pHD24 (E), and pHD108 (F).  
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Little or no ANTS leakage is observed at pH 7 for the pHD peptides, even at the highest 
concentrations measured. In Figures 2-2D-F, we show the leakage as a function of pH for pHD15, 
pHD24, and pHD108. At the concentrations shown, leakage sharply transitions to 100% with 
decreasing pH. The transition as a function of pH is  steep. Again, pH50 increases as peptide 
concentration is increased, with a shift of about 0.3 pH units when the peptide concentration is 
increased from P:L = 1:200 to 1:50. For pHD24 and pHD108, the pH50 increases from 6.0 to 
~6.4. For pHD15, the pH50 is lower; it increases from 5.6 to 5.9 as peptide concentration is 
increased from 1:200 to 1:50.   
Binding of the pHD peptides to membranes 
We characterized the binding of the peptides as a function of pH and peptide concentration with 
tryptophan fluorescence titration45. As shown in Figure 2-3A, the fluorescence emission 
maximum shifts from ~350 nm at neutral pH to 330 nm at acidic pH, indicative of a transition 
from aqueous, exposed tryptophan to membrane-inserted tryptophan45. In Figure 2-3B, we show a 
kinetic trace of binding at pH 4.5, under conditions at which the peptide is active. Upon addition 
of peptide to a 1 mM vesicle solution at t = 8 minutes, binding occurs rapidly, and is essentially 
complete in 1 minute. In Figure 2-3C-E, we show the scaled fluorescence intensities at 335 nm as 
a function of pH for different peptide concentrations for pHD15, pHD24, and pHD108. In all 
cases, binding is dependent on pH with a sharp transition occurring over about 1 pH unit, which 
is indicative of cooperativity. Peptides pHD108 and pHD24 show a small increase in pH50 and a 
sharper slope as peptide concentration is increased. The pH50 increases from 5.1 to 5.6 for 





Figure 2-3: pHD peptide binding to lipid bilayers, as followed by tryptophan 
fluorescence.  
Each pHD peptide has one tryptophan, and its fluorescence is sensitive to the polarity of 
its environment. (A) Fluorescence spectra of pHD15 as a function of pH ranging from 4 
to 7. Samples with 10 μM pHD15 and 1 mM POPC (P:L = 1:100) were incubated for 1 h 
before spectra were recorded. The dotted line is at 334 nm. (B) Time course of pHD108 
tryptophan fluorescence. Upon addition of vesicles at about t = 5 min, binding is rapid. 
(C–E) Normalized fluorescence as a function of pH for pHD15 (C), pHD24 (D), and 




Acquisition of secondary structure upon membrane binding 
To determine the secondary structure of the peptides, we used circular dichroism (CD) 
spectroscopy. We could only study peptides at the highest three peptide concentrations because 
the technique lacks high sensitivity. As shown in Figure 2-4A, the CD spectra of the pHD 
peptides transition from a spectrum typical of a random coil with one minimum at 200 nm at pH 7 
to a spectrum characteristic of an -helix with two minima at 208 and 220 nm at pH 4.5. The 
spectra indicate that the pHD peptides undergo transitions from random coil to -helix as pH is 
decreased from 7 to 4.5.  In Figure 2-4B-D, we show the relative % helicity as a function of pH 
and P:L for pHD15, pHD24, and pHD108. Folding, like binding and leakage, is dependent on pH 
and exhibits a cooperative transition occurring over 1 pH unit. All peptides show little to no 
change in pH50 as peptide concentration is increased over the available range. The pH50 for 
pHD15 is 5.3 ± 0.1 for all P:L. For pHD24, the pH50 increases from 5.3 to 5.5, and for pHD108 
the pH50 increases from 5.4 to 5.5 as P:L increases from 1:200 to 1:50.  
Comparison of pH50 values for binding, folding, and leakage of vesicle contents  
In Figure 2-5, we compare the pH dependence of binding, folding, small molecule leakage and 
macromolecular leakage for the three highest peptide concentrations, for pHD15, pHD24, and 
pHD108. Several features are common for all peptides, at all P:L ratios. First, the differences in 
pH50 values for binding and helicity are not statistically significant, which is expected, given the 
binding-folding coupling that is typical of membrane active peptides108.  pH50 for binding and 
structure also do not depend strongly on peptide concentration (discussed below). Second, the 
differences in pH50 for dextran and ANTS/DPX leakage are not statistically significant, with one 




Figure 2-4: Secondary structure of the pHD peptides as a function of pH.  
(A) Circular dichroism spectra of pHD108 at P:L = 1:200, measured after 1 h of 
incubation with 1 mM POPC vesicles. Separate samples were made for each pH. (B–D) 
The % helicity, measured as a function of pH, was calculated from the absorbance at 222 





Figure 2-5: Comparison of pH50s  
for binding (BD), folding (CD), ANTS/DPX leakage (ANTS), and TAMRA-biotin-
dextran leakage (TBD) pKa’s. Significance was calculated by ANOVA and a Tukey test 
for multiple comparisons, where **** indicates P< 0.0001, *** indicates P = 0.0001 to 




significantly lower than pH50 for leakage. This effect is most pronounced at high peptide 
concentrations, a consequence of the observation in Figure 2-1 and 2-2 that the pH50 values for 
leakage increase with increasing peptide concentration.  
Comparison of binding and dextran leakage pH50s 
An intriguing consequence of the higher pH50 of leakage than of binding and folding is that at 
high overall peptide-to-lipid ratio, leakage is high despite the fact that binding and helicity appear 
to be negligible. In Figure 2-6, we compare the binding and dextran leakage curves for pHD15, 
pHD24, and pHD108 as a function of pH and peptide-to-lipid ratio. At P:L = 1:50 (top row), the 
binding and leakage curves are offset such that the pH50 for binding is lower than that for 
leakage. At high P:L, the greatest discrepancies in the fraction bound and fraction leakage occur 
at intermediate pHs. For example, at pH 5.75, pHD15 induces 96% TBD leakage when only 3% 
of the peptide is bound. At low P:L, the converse is true: leakage is close to zero despite the fact 
that the fraction bound is high. At P:L = 1:5000, the pH50 for binding for pHD15 is 5.12 ± 0.05. 
The pH50 for leakage cannot be calculated since no leakage is observed at any pH. The large 
discrepancies between fraction bound and fraction leakage indicate that the fractional leakage is 
not dependent on the fraction of peptide bound or folded. 
Leakage is dependent on the number of peptides bound per vesicle 
We sought to explain the discrepancies between fractional leakage and fraction bound by 
accounting for the actual amount of peptide that is bound to membranes under the different 
conditions. Since only bound peptides can induce pore formation, we calculated the number of 
peptides that are bound per lipid, under each condition, to determine if leakage scales with this 




Figure 2-6: Comparison of binding and dextran leakage activity curves as a function 
of pH and P:L.  
At the highest P:L, 100% leakage is possible when only a small fraction of peptide is 





Figure 2-7: Activity of the pHD peptides depends on the number of bound peptides 
per vesicle. 
 (A) Dextran leakage as a function of bound peptide per lipid for the three peptides: red, 
pHD15; green, pHD24; and blue, pHD108. Leakage (50%) occurs when roughly 1 
peptide is bound per 1300 lipids. (B) The same as in panel A but replotted as a function 
of bound peptides per vesicle, assuming that each vesicle has ∼90 000 lipids. The 
different colors indicate the different pH values used in the experiment. Leakage (50%) 
occurs when on average 75 peptides are bound per vesicle. (C) Poisson distribution of 
peptides per vesicle, when averages are 10, 75, and 250 peptides per vesicle. The data in 
panel B show that in these three cases we observe no leakage, 50% leakage, and 100% 
leakage, respectively. This result can be rationalized, as we calculate that 20–30 peptides 
are needed to form a barrel-stave pore of ∼4.5 nm diameter to allow for the passage of 40 
kDa dextran. Thus, no leakage is expected when fewer than 20 peptides are bound per 
vesicle. Only partial leakage is expected when ∼75 peptides are bound. Leakage (100%) 
is expected when more than 200 peptides are bound per vesicle.  
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(red), pHD24 (green), and pHD108 (blue). Plotted in this way, all of the data for all three pHD 
peptides can be fitted by a single curve (solid black line), indicating that the pHD peptide 
function depends solely on the amount of bound peptide. Leakage of 50% occurs when 1 peptide 
is bound per 1,300 lipids, a manifestation of the exquisite potency of the pHD peptides as we 
know of no other peptide, except the closely related macrolittins24, that approach this potency for 
macromolecular poration. 
Assuming an area per lipid of 70 Å2,109 it can be estimated that there are about 100,000 
lipids per vesicle81. In Figure 2-7B, we rescale the data in Figure 2-7A, now plotting the leakage 
as a function of bound peptides per vesicle. The different colors in Figure 2-7B indicate the 
different pHs, and provide an illustration of the fact that the pH controls function entirely by 
controlling the amount of bound peptide. In Figure 2-7B we further see that 50% leakage occurs 
when only 75 peptides are bound per vesicle.  
To rationalize these data, in Figure 2-7C we plot the Poisson distribution of peptides per 
vesicle, when averages are 10, 75, and 250 peptides per vesicle, corresponding to the cases of  no 
leakage, 50% leakage, and 100% leakage (according to Figure 2-7B). We further estimate the 
number of peptides that are required to line a pore that permits passage of a 40 kD dextran 
through the bilayer. In particular, we reason that the pore must have a radius that is at least equal 
to the hydrodynamic radius of 40 kDa dextran, 4.5 nm. If we assume that the peptides are in 
contact with each other and that the diameter of the pHD helix, with side chains included, is 1.2 
nm, we calculate that 20-30 peptides are required to line the perimeter of such a pore. This is 
called a barrel-stave pore59. Thus, little macromolecule leakage can be expected when fewer than 
20 peptides are bound per vesicle, consistent with the experiment. At least partial leakage 
becomes possible once the 20-30 peptide cut-off is exceeded. It is also possible that the peptides 
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form toroidal pores, lined by both peptides and lipid headgroups59.  In this case, fewer peptides 
would be required to line the pore. On the other hand, some peptides could line non-productive 
pores with diameters that are too small to allow the passage the 40 kDa dextran. Overall, the 
partial leakage that is observed experimentally at <100 peptides per vesicle is consistent with 
most of the vesicle-bound peptides participating in one or a few pores. 
Dynamics of peptide association with membranes 
Since a small fraction of bound peptides can cause substantial leakage, it is possible that the pHD 
peptides can exchange between vesicles and induce pores on multiple vesicles while the overall 
fraction of bound peptide remains low. We tested this possibility by evaluating if membrane-
bound pHD15 can transfer to new vesicles composed of the brominated lipid, diBrPSPC. The 
bromines, located on the 9,10 positions on the acyl chains of the lipids, will quench tryptophan 
when the peptide is bound to membranes46 (Figure 2-8A). Therefore, exchange from POPC to 
diBrPSPC will lead to quenching.  To test for this possibility, pHD15 was incubated with 1 mM 
POPC vesicles at pH 4.5, where ≥95% of the peptides are bound (Figure 2-3C). After 0.2 mM of 
POPC or diBrPC vesicles were added, the tryptophan fluorescence intensity decreased (Figure 2-
8B). The decrease caused by PC vesicles can be explained by dilution, however the rapid and 
much larger decrease into diBrPC vesicles suggests that peptides, initially bound to POPC 
vesicles, are rapidly quenched by diBRPC lipids with a halftime of a few seconds. Quenching is 
greater when more diBrPSPC is added (Figure 2-8C). Most likely, the observed quenching is due 
to rapid transfer of peptides between vesicles. However, it is also possible that the peptides 





Figure 2-8: Quenching of tryptophan fluorescence by the redistribution of pHD 
peptides.  
(A) pHD15 bound to vesicles composed of diBrPSPC displays quenched fluorescence. 
Peptide at 20 μM was incubated with 1 mM vesicles at pH 4.5 for 1 h before the emission 
spectra of tryptophan was measured (ex = 270, em = 280–500 nm). Peptides in the 
presence of vesicles composed of POPC or diBrPSPC show blue-shifted fluorescence, 
indicating that the peptide is bound. However, the tryptophan peak, in the presence of 
brominated lipids, is 87% lower in intensity. (B) Tryptophan fluorescence as a function 
of time upon the addition of a second batch of vesicles. Original samples are prepared 
with 1 mM vesicles. At t = 500 s, 20 μM pHD15 is added. After about 30 min, 0.2 mM 
POPC or diBrPSPC vesicles are added to the cuvette. (C) Same time course as in panel B, 







Here we have studied membrane interactions, secondary structure, and function of the pHD 
peptides across a range of peptide concentrations and pH values to better understand their 
sequence-structure-function relationships. Overall, the observed dependencies of binding, 
structure and membrane permeabilization on pH are sigmoidal with sharp transitions that occur, 
in most cases, over ~1 pH unit. In comparison, an unaltered protonation equilibrium will be much 
shallower; e.g. protonation as described by the Henderson-Hasselbalch equation occurs over 
about 2.6 pH units, for a 5% to 95% transition. This suggests that the protonation/deprotonation 
of the acidic residues occurs synergistically. The free energy of membrane binding likely 
contributes to the observed cooperativity. The pH50 values, ranging from 5.0 to 6.4 for the 
various measurements reported here, are significantly higher than the inherent pKa values of 
isolated Asp and Glu side chains, (~3.5), further implying that there are significant interactions 
between these side chains and that they are not acting independently. Indeed, the charges 
engineered into the pHD library are positioned with helical spacings so that they will repel one 
another maximally when the peptide has -helical structure. The very fact that the screen selected 
only for peptides with five or six acidic residues suggests that the synergistic interactions between 
the charges is critical for pHD function.  
Cooperativity in binding 
For peptide binding, positive cooperativity with peptide concentration will arise if there 
are strong attractive interactions between peptides in the membranes that are at least as energetic 
as the peptide-membrane interactions. This can occur if peptides self-assemble tightly into higher 
order oligomeric structures in the membrane. While this effect has been reported at least once110, 
it is not frequently  observed, probably because membrane partitioning is inherently stronger than 
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the likely magnitude of peptide-peptide interactions in membranes. Alternately, if the presence of 
peptides in the membrane changes the membrane structure in a way that improves the binding of 
additional peptides, positive cooperativity could be observed. This scenario could occur, for 
example, if the expansion of a membrane pore is more energetically favorable (or less costly) 
than its initial formation of the pore.  
For the pHD peptides, positive cooperativity will result in a rightward shift of the pH-
binding curves for higher total peptide concentration. With pHD24 and pHD108, we indeed 
observed small upward shifts in pH50 for binding at the highest peptide concentrations, 
suggesting positive cooperativity (Figure 2-3). However, given that the peptide concentrations 
varied by 100-fold, the cooperativity is small. The binding of one peptide to the bilayer is not 
strongly influenced by the presence of other peptides already bound to the membrane. Peptide-
membrane interactions are dominant over peptide-peptide interactions. Thus, we can describe 
pHD peptide binding and folding in classical thermodynamic terms of membrane 
partitioning81,82,111.  
Coupling of binding and folding 
The actions of peptides that bind to membranes are usually considered within the 
framework of a canonical thermodynamic model that includes coupled partitioning of the peptide 
into the membrane and acquisition of secondary structure111,112. This well-supported concept of 
binding-folding coupling is a consequence of the high energetic penalty of partitioning open 
peptide bonds into the membrane, relative to a peptide bond that is involved in hydrogen bonded 
secondary structure112. For the pHD peptides the observable properties are intentionally coupled 
to the protonation states of the 5 or 6 acidic residues that were identified in the high-throughput 
screen22. Potential acidic residues in the library were placed with helical spacing patterns to 
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maximize their influence on binding and structure propensity. Here, we show that binding and 
folding have very similar dependencies on peptide concentrations and pH, at least for the 
conditions under which both could be measured. We observe a small positive cooperativity in 
binding that is not apparent in secondary structure measurements, but the latter is a less sensitive 
measurement overall and can only be measured for the highest few peptide concentrations. In any 
event, the pH50 values for binding and folding are not significantly different from one another 
(Figure 2-5). They are coupled; binding does not occur without folding and folding does not 
occur without binding. The steepness of the pH curves and the upward shift in pH50 compared to 
free carboxylate groups shows that there is also coupling of protonation to binding and secondary 
structure. The fully deprotonated peptides do not interact with membranes or fold into -helices, 
while protonation of at least some acidic sidechains enables membrane interaction and folding. 
The pH- and concentration dependence of permeabilization 
We also measured the dependence of function, membrane permeabilization to 
macromolecules, on pH and peptide concentration. The behavior of function is very different 
from binding and structure. In this case, the pH50 values and slopes vary significantly with total 
peptide concentration. At the highest peptide concentrations, the pH50 values for leakage are 
highest, and the pH curves are steepest. As peptide concentration is decreased, pH50 and slope 
both decrease. However, slopes, when measurable, are never as shallow as predicted for simple 
protonation equilibrium, and pH50 values are never as low as expected for a water-exposed 
carboxyl sidechain.  
For comparison, we also measured the pH50 values for leakage of the small molecule 
ANTS at several peptide concentrations. The pH50 values for ANTS leakage and for dextran 
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leakage are statistically indistinguishable from one another. This demonstrates that pore 
formation for small molecules and for macromolecules are not distinct processes. 
Coupling of binding and poration 
Interestingly, the functional data show that efficient poration can occur at pH values 
significantly higher than those that enable efficient binding, an effect that becomes greater for 
higher peptide concentrations (Figure 2-6). Indeed, there are pH values at which substantial 
macromolecule leakage occurs despite the fact that fractional binding and folding are very small. 
There are also conditions where there is no leakage despite 100% binding (Figure 2-6, bottom 
row).  It might seem paradoxical that binding/folding are not tightly coupled to function 
(poration). However this paradox is resolved when we consider the dependence of vesicle 
permeabilization on the peptide bound per lipid, rather than total peptide per lipid (Figure 2-7). 
When the functional data are plotted as a function of Pbound:L (i.e. the actual concentration of 
peptide acting on the membranes), the curves, slopes and pH50 values for the various 
concentrations become similar for all three peptides under all conditions. Leakage depends 
primarily on how many peptides are bound per vesicle, and thus binding and poration are in fact 
tightly correlated. The apparent paradox occurs because a small fractional binding can drive 
efficient permeabilization under conditions when Ptotal:L is much higher than the Pbound:L required 
for permeabilization.  
It is interesting to note that the poration curves as functions of Pbound:L behave as single 
function despite data that was collected between pH 4.5 and pH 6.5. We conclude from this 
observation that the structure of the pore is not sensitive to pH in this range. As long as the 
protonation state enables some pHD peptide to bind, the pore can be formed. 
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Potency, or the number of peptides required to permeabilize a vesicle.  
The plot of macromolecule leakage versus Pbound:L in Figure 2-7A shows that the 
concentration that drives 50% permeabilization of PC vesicles to 40 kDa dextran is around 
Pbound:L = 1:1300, under all conditions. This is equivalent to 75 peptides per vesicle. The only 
other membrane permeabilizing peptides known that have this degree of potency for releasing 
macromolecules from PC vesicles are the closely related macrolittins24, which were selected from 
the same library.  
Assuming random dispersal of peptides, a Poisson function will describe the distributions 
of the number of peptides per vesicle (Figure 2-7C).  Based on the calculation that 20-30 peptides 
are needed to form a barrel-stave pore of ~ 4.5 nm diameter to allow for the passage of 40 kDa 
dextran (4.5 nm hydrodynamic radius), we can expect no leakage when fewer than 20 peptides 
are bound per vesicles, and indeed we observe no leakage in this case. Only partial leakage can be 
expected when 75 peptides are bound. Consistent with this expectation, experimentally we 
observe 50% leakage when 75 peptides are bound per vesicle (Figure 2-7B). We observe 100% 
leakage once about 200 peptides are bound to each vesicle. 
Possible pore structure 
The highly potent macromolecular leakage and the large pores they imply suggest a 
structural hypothesis for the pHD peptides. At low pH, when at least some of the acidic groups 
are protonated, the pHD peptides bind to membranes and fold into amphipathic -helices. We 
hypothesize that these amphipathic helices stabilize exposed bilayer edges, enabling the otherwise 
energetically unfavorable formation of large open pores. We envision that the amphipathic 
helices lie at the bilayer edge, exposing charged and polar groups to the aqueous phase while 
exposing the hydrophobic surfaces of the helices to the bilayer. Perhaps the pore edges are further 
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stabilized by lateral electrostatic interactions between acidic sidechains and the two basic residues 
on the pHD peptides.  
Our recent description of the macrolittins24, closely related peptides that also have very 
potent macromolecular poration activity at pH 7, supports these conclusions. The macrolittins 
were selected from the same library as the pHD peptides, except that they were selected for their 
ability to permeabilize bilayers to macromolecules at pH 7. They are nearly identical to the pHD 
peptides in sequence, structure and potency, except that they have three acidic residues total, 
compared to five or six in the pHD peptides. In the pHD peptides, protonation of several residues 
in the other acidic positions enables the pore structure to form only at acidic pH, while in the 
macrolittins this pore structure is possible at pH 7 because of the smaller number of acidic 
residues. 
By oriented circular dichroism, the parent peptide of the pHD library, MelP5, resides in a 
mostly membrane spanning, perpendicular orientation33. The same is true for the macrolittins24. 
Thus, it is likely that the pHD peptides are also mostly perpendicular to the membrane plane at 
acidic pH. However it is difficult to study the orientation of the pHD peptides because it is 
difficult to control or determine the effective pH in the typical oriented CD sample, a stacked 
multibilayer system that is hydrated through the vapor phase35,84,113. Further, AFM has shown that 
MelP5 causes membrane thinning in the vicinity of the pores, while the macrolittins and pHD 
peptides cause pores, but not much membrane thinning24,114. Thus, by progressing from MelP5 to 
the pHD peptides and macrolittins, we have evolved peptides that more effectively span the 
bilayer “edge” and enable large pores to form in the membrane.  
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The effect of sequence 
The physical chemistry and sequence of the pHD peptides affects their potency and pH 
dependence. For instance, pHD15, has a lower potency and a lower pH50 compared to the other 
two peptides (Figure 2-1), suggesting a sequence-dependent effect that may be due to the number 
of acidic residues; pHD15 is the only pHD peptide with six acidic residues, instead of the usual 
five. On the other hand, the most potent peptide, pHD108, has 5 glutamic acids, which were 
significantly overrepresented in the pHD sequences, whereas pHD15 and pHD24 have 3 and 2 
aspartic acids, respectively. These observations of sequence-specific effects suggest that 
additional changes in sequence, which can be either rationally engineered or identified via high-
throughput screens from peptide libraries, can be used to fine-tune the properties of the pHD 
peptides for desired applications.  
Conclusion 
Here we study the mechanism of action of the pHD peptides, which form large pores in POPC 
bilayers in a pH-dependent manner. The activity of these highly potent peptides is controlled by 
both pH and peptide concentration, and ultimately depends on the number of peptides that are 
bound per vesicle.  The physical chemical sequence-structure-function relationships that we 
described here will be useful in the future design and optimization of membrane permeabilizing 
peptides for specific applications. Such applications could include the release of endosomal 
contents for drug delivery upon acidification, as well as anti-cancer therapies that exploit the low 
pH of the tumor environment. 
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CHAPTER 3: EFFECT OF LIPID COMPOSITION 
ON THE ACTIVITY OF PHD15 
Abstract 
Peptides that self-assemble into pore-like structures in lipid bilayers could have utility in a variety 
of biotechnological and clinical applications due to their ability to breach the barrier imposed by 
lipid bilayers. To empower such discoveries, we have used synthetic molecular evolution to select 
for the pHD peptides, a family of membrane-active, pore-forming peptides that assemble into 
macromolecular pores at acidic pH. Since cell membranes are complex, with lipids of various 
headgroups and acyl chains, we sought to determine the effect of lipid composition on pHD 
activity. To understand the effect of anionic headgroups and acyl chain length on the mechanism 
of action of the pHD peptides, we measured the binding and activity of pHD15 on vesicles 
composed of 1:9 POPS:POPC, 1:9 POPG:POPC, as well as PC lipids with singly unsaturated 
acyl chains ranging from 14 to 22 carbons in length. We find that pHD15 retains its pH-
sensitivity, and is extremely sensitive to the composition of the bilayer. The peptide partitions 
equally favorably to anionic and neutral membranes, and is equally potent in 1:9 POPG:POPC 
and POPC membranes, but less potent in 1:9 POPS:POPC membranes. The peptide binds to 
membranes of various thicknesses in a pH-sensitive manner that is affected by the chain lengths. 
Leakage is decreased for thicker membranes, which cannot be accounted for by the amount of 
peptide bound. Noteworthy, pHD15 is most potent in POPC membranes, the lipid composition 
used when screening for the peptides. Taken together, the data highlights the power of 




pH-sensitive, pore-forming peptides can be useful for a variety of biotechnological applications, 
such as delivery agents for the endosomal escape of cargo to the cytoplasm or as therapeutics that 
target cancer cells. However, cell membranes are composed of hundreds of different lipid species 
that affect the physical properties of the membrane115–119, and consequently the activity of 
membrane-active peptides. In particular, membrane thickness and charge have been shown to 
modulate the insertion, aggregation, and activity of peptides101,120–127.   
 The pHD peptides are 26 amino acid peptides that bind to membranes, fold into alpha 
helices, and cooperatively assemble into macromolecular-sized pores under acidic conditions. My 
work in the previous chapters has shown that pH, peptide concentration, and sequence modulate 
the number of peptides bound per vesicle. When greater than 75 peptides are bound per vesicle, 
the peptides act cooperatively to form pores in neutrally charged, POPC membranes25.  
Here, I test the effect of anionic headgroups and acyl chain length on the activity of one 
of the pHD peptides, pHD15 (sequence: GIGEVLHELADDLPDLQEWIHAAQQL). When 
selecting anionic lipids, we chose the lipid POPS, which is found in mammalian cell 
membranes128. Furthermore, the lipid has palmitoyl (16:0) and oleyol (18:1) acyl chains, which 
permits comparison with POPC, the lipid used to characterize the activity of the pHD peptides in 
Chapter 225. We also used POPG, another lipid with an anionic headgroup that is commonly used 
129–131. We selected a lipid composition of 1:9 POPS:POPC and 1:9 POPG:POPC (hereafter 
referred to as 10% POPS or 10% POPG) to study the effect of anionic membranes on the binding 
and pore-forming activity of pHD15. To measure binding and poration, we used the tryptophan 
fluorescence assay and the FRET-based dextran leakage assays. 
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 We further note that cells are composed of lipids of various acyl chains which can 
modulate membrane thickness109. Hydrophobic mismatch may play a role in membrane protein 
segregation, activation, trafficking, and membrane protein stability132–134. To study the effect of 
membrane thickness on pHD15 binding and activity, the bilayer thickness was varied by using 
phosphatidylcholine headgroup lipids with acyl chain lengths ranging from 14 to 22 carbon atoms 
and containing cis double bonds. The binding and pore-formation of pHD15 to these membranes 
was measured by tryptophan fluorescence and dextran leakage assays. 
 We find that the peptides retain their pH-sensitivity and are exquisitely sensitive to lipid 
composition. pHD15 is most potent in POPC and 10% POPG membranes, and less effective in 
10% POPS and thicker membranes. Notably, the high throughput screens used to discover the 
pHD peptides were performed with POPC vesicles, the lipid composition for which the peptides 
are most potent. Thus, my data show that high throughput screening is highly effective in 
selecting for peptides that have precisely the behavior we screen for.  
 
Results 
Macromolecular leakage across anionic membranes in response to pHD15 
To evaluate the effect of anionic membranes on the function of pHD15, dextran leakage assays 
were performed to assess macromolecular poration of a bilayer by pHD15. In this FRET-based 
assay (Figure 3-1A), the acceptor molecule, TAMRA-Biotin-Dextran (TBD), is encapsulated 
inside vesicles. The dextran is 40 kDa in size. The donor molecule, streptavidin-AlexaFluor488 
(SA-AF488), is outside the vesicles. If large pores form while the peptide is incubated with these 
vesicles, streptavidin and biotin will come into contact, placing the acceptor and donor 




Figure 3-1: Macromolecular leakage across anionic membranes in response to 
pHD15. 
Schematic of the FRET-based dextran leakage assay to measure the formation of large pores (A). 
Leakage of 40 kDa dextran from vesicles composed of 10% POPG and 10% POPS at pH 4.5 (B) 
and pH 5.5 (C). Peptide was incubated with 1 mM lipid for 1 hour before FRET was measured. 




In Figure 3-1B,C we show the fractional leakage of TBD, measured after 1 hour, as a 
function of peptide-to-lipid ratio (P:L) and pH. At the lowest peptide concentrations, little or no 
leakage is observed at any pH. As the peptide concentration increases, leakage increases to 100%. 
At pH 4.5, the peptide is most potent in POPC membranes (LIC50 of 1:520 P:L), less potent in 
10% POPG membranes (LIC50 of 1:260) and least potent in 10% POPS membranes (LIC50 of 
1:120).  At pH 5.5, the peptide is similarly potent in POPC and 10% POPG membranes (LIC50 = 
1:200), and less potent in 10% POPS membranes (LIC50 = 1:65).  
Partitioning of pHD15 to anionic membranes 
To determine if anionic headgroups affect the binding of pHD15 to membranes, we measured the 
extent of peptide binding to membranes composed of POPC, 10% POPS or 10% POPG by 
tryptophan fluorescence as a function of pH and peptide concentration on. pHD15 has one 
tryptophan residue, with a fluorescence that is dependent on the polarity of its environment. 
Tryptophan’s fluorescence is higher in hydrophobic environments like that within the 
hydrocarbon core of the membrane, and lower in hydrophilic environments like that of the 
solution phase (Figure 3-2A). The peptide was incubated with LUVs for 1 hour before tryptophan 
fluorescence was measured. The nanomoles of peptide bound per lipid was calculated and shown 
in Figure 3-2B. At pH 4, the amount of peptide bound per lipid increases as the total peptide to 
lipid increases, with nearly all peptide bound to the membrane. As the pH increases, the number 
of peptides bound per lipid decreases, until there are no peptides bound at pH 7. Equivalent 
amounts of peptide are bound to POPC, 10% POPG, and 10% POPS membranes, suggesting that 




Figure 3-2: Binding of pHD15 to neutral and anionic membranes. 
Binding of pHD15 to vesicles composed of POPC, 10% POPG, and 10% POPS 
membranes as measured by tryptophan fluorescence. (A) Tryptophan fluorescence 
measured after a 1 hour incubation of peptide with 10% POPG membranes at P:L = 1:50. 
The fluorescence from 330-335 nm, as indicated by the gray region, was averaged to 
calculate the percent of peptide bound. (B) The percent of peptide bound was used to 





Folding of pHD15 in anionic membranes 
To determine the folding of pHD15 in anionic membranes, circular dichroism spectra was 
measured as a function of pH and P:L after incubating the peptide with 10% POPS membranes 
for 1 hour (Figure 3-3A). The extent to which the peptide had formed a helix was calculated from 
the average ellipticity at 217-227 nm. The relative percent helicity is shown as a function of 
peptide concentration and pH in Figure 3-4B-D. For all peptide concentrations, little peptide is 
helical at pH 7. As the pH decreases, increasing fractions of the peptide are folded. The pHs at 
which 50% helix is measured, or the ‘pH50’, are 5.6-5.7 for POPC membranes and 5.4 for 10% 
POPS membranes. By ANOVA, the differences between the pH50s for POPC and 10% POPS 
membranes are not statistically significant at any concentration, suggesting that anionic 
headgroups do not promote nor inhibit the folding of pHD15 into alpha helices.   
Macromolecular leakage across membranes of increasing thickness in response to 
pHD15 
To characterize the macromolecular leakage of macromolecules through membranes of increasing 
thickness, we used the same dextran leakage assay described for anionic membranes. Leakage 
was measured as a function of pH and peptide concentration through membranes composed of 
lipids with singly unsaturated acyl chains of 14, 16, 18, and 20 carbons (Figure 3-4). The extent 
of leakage depends on pH. There is no leakage at pH 7, and leakage increases as the pH 
decreases. The transition from 0 to 100% leakage occurs over 0.5 to 1 pH units. The pH50 is 
dependent on concentration, with the pH50 decreasing as peptide concentration decreases. For the 
thinnest membranes, composed of lipids with 14 acyl chain carbons, the pH50 decreases from 
5.96 at P:L = 1:50 to 5.41 at P:L = 1:200. Negligible leakage is detected at P:L = 1:1000 and P:L 
= 1:5000, even under acidic conditions. For membranes with intermediate chain lengths of 16 or 




Figure 3-3: Folding of pHD15 on 10% POPS membranes. 
pHD15 was incubated with 10% POPS membranes for 1 hour before the circular dichroism 
spectra were measured. Shown is an example set of CD spectra at P:L = 1:100 (A). The helicity 
was calculated with the average ellipticity from 217-227 nm, then normalized between 0 and 1 at 
a P:L of 1:50 (B), 1:100 (C), and 1:200 (D). The P-value of the pH50s were calculated in Prism 
with ordinary one-way ANOVA. Standard errors used in the calculation of the P-values were 
determined to be 0.05 by a simulation for P:L = 1:50 and 1:100. For P:L = 1:200, the error 





Figure 3-4: Macromolecular leakage across membranes of increasing thickness in 
response to pHD15. 
pHD15 was incubated for 1 hour at room temperature with 1 mM lipids before leakage 
was measured. This experiment was performed with membranes composed of PC-





becomes thicker.  
The pH50 decreases from 5.96 for C14 membranes to 5.39 for C18 membranes. No 
leakage is detectable at any pH with C16 membranes at P:L = 1:1:1000, and with C18 membranes 
at P:L = 1:500. Very little activity is observed at any P:L or pH with C20 membranes, with only 
about 10% leakage at the conditions where leakage is most likely to occur at P:L = 1:50 and pH 
4.5 (Figure 3-4D). These observations suggest that pore-formation is most efficient in thin 
membranes, less efficient at membranes of intermediate thicknesses, and inefficient in the 
membranes of greatest thickness. 
Partitioning of pHD15 into membranes of increasing thickness  
To determine the extent to which peptides bind to membranes of increasing thickness, we 
measured the binding of pHD15 to membranes composed of PC-headgroup lipids with singly 
unsaturated acyl chains of 14, 16, 18, 20, or 22 carbons using tryptophan fluorescence. In Figure 
3-5, we show the normalized, average fluorescence intensities at 330-335 nm as a function of pH 
and lipid composition for pHD15.  
For all concentrations, binding is dependent on pH, with little to no peptide bound at pH 
7, and increasing amounts of peptide bound as the pH becomes more acidic. The pH50 depends 
on peptide concentration and the number of carbons in the acyl chains of the lipids. For the 
thinnest membranes, composed of lipids with 14 carbons in the acyl chains (Figure 3-5A), the 
peptide is most active at P:L = 1:50, the highest peptide concentration for which binding was 
measured, and least active at the lowest peptide concentration of P:L = 1:1000. The ∆pH50, 
defined as pH50P:L=1:50 – pH50P:L = 1:1000 is about 0.8 pH units. The difference between the 
pH50P:L=1:50 and pH50P:L = 1:1000 is highly significant (P < 0.0001, calculated in Prism using 
ordinary one-way ANOVA). For membranes of intermediate thicknesses (Figures 3-5B, C), the 




Figure 3-5: Binding of pHD15 to increasingly thicker membranes, as monitored by 
tryptophan fluorescence.  
Binding of pHD15 to vesicles composed of singly unsaturated acyl chains of 14 (A), 16 
(B), 18 (C), 20 (D), and 22 (E) carbons was measured by tryptophan fluorescence after 1 
hour incubation with 1 mM lipids at a P:L of 1:50 to 1:1000. The average fluorescence at 






Figure 3-6: Change in pH50 of binding curves, acquired for pHD15 binding to 
membranes of various thicknesses. 
The pH50s were calculated by a sigmoidal fit of the tryptophan fluorescence versus pH curves 
shown in Figure 3-5. The pH50s (A) were plotted as a function of acyl chain carbons. The slopes 





C16 membranes (P = 0.046), and -0.3 pH units in C18 membranes (P = 0.0003). Notably, 
although the P:L dependence of pH50 is slight, in C18 membranes, there is an inversion of 
dependence on peptide concentration, with the peptides being most active at P:L = 1:1000 and 
least active at P:L = 1:50. For the thickest membranes, the inverse relationship between peptide 
concentration and pH50 is magnified (Figure 3-5D,E). Indeed, the ∆pH50 for C20 membranes is -
0.7 pH units (P < 0.0001), and the ∆pH50 for C22 membranes is -0.8 pH units (P < 0.0001).  
The change in pH50s as a function of the number of acyl chain carbons is summarized in 
Figure 3-6A, and the slope of these curves are plotted in Figure 3-6B as a function of peptide to 
lipid ratios. For the thinnest membranes, the pH50 increases as concentration increases, 
suggesting a cooperative process, i.e., binding becomes more efficient as the concentration of 
peptides increases. For the thickest membranes, the pH50 decreases as peptide concentration 
increases, suggesting an anti-cooperative process, i.e., binding becomes less efficient as the 
concentration increases. For membranes of intermediate thicknesses, there is a convergence of 
pH50s centered at around slightly greater than 16 carbons. Intriguingly, the pH50s for different 
peptide concentrations coincide at about 17 carbons, which is the average number of carbons on 
POPC acyl chains, for which the pH50s also coincide25. 
Orientation of pHD15 in membranes of increasing thickness 
Pore-formation is likely mediated by peptides that are oriented perpendicular to the plane of the 
bilayer. To determine the orientation of the peptide in thin and thick membranes, the oriented 
circular dichroism spectra of pHD15 were measured in C14 and C22 membranes. In C14 
membranes, the dry spectrum exhibits two dips with peaks at 212 and 222 nm (Figure 3-7A). This 
shape is generally consistent with a peptide that is parallel to the membrane35,84. After about 70 




Figure 3-7: Oriented circular dichroism spectra of pHD15 in membranes of 
different thickness. 
Comparison of the OCD spectra of pHD15 in stacked, oriented bilayers composed of C14 
lipids (A) on a quartz substrate in the dry state and after 70 minutes of hydration with 
water through the vapor phase. The average of eight spectra measured at 45° rotations of 
the sample around the beam axis are shown. The lipid only spectra have been subtracted, 
and a correction has been made for the baseline. (B) The OCD spectrum of pHD15 on 
hydrated C14 membrane is shown in blue, and dry and theoretical OCD spectrum are 
shown in black. Linear combinations of the basis spectra, in increments of % 
perpendicular helix increasing by 10% per step, are shown in gray. The best fit spectrum, 
representing ~20% perpendicular helix, is in orange. (C). Time course of the evolution of 
the OCD spectrum. (D). Comparison of the OCD spectra of pHD15 in C22 membranes in 
the dry state and 85 minutes after hydration.  
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such that the intensity of the 212 nm peak decreases. This likely suggests a transition towards a 
transmembrane state with a theoretical spectrum with one dip shown in Figure 3-7B. The 
hydrated spectrum is assumed to be a linear combination of the dry spectrum and the spectrum of 
a helical peptide in a transmembrane orientation. Under this assumption, the spectrum 
corresponds to about 20% of the peptides in the transmembrane orientation, suggesting that the 
peptide has partially inserted into the membrane. We monitored the change in pHD15’s OCD 
spectra in C14 membranes as a function of time after hydration (Figure 3-7C). The change in the 
shape of the spectrum occurs over time, with no further changes after 70 minutes. The transition 
suggests that the change in orientation occurs slowly, and that the peptide may have been 
kinetically trapped in an orientation parallel to the surface of the membrane.   
In C22 membranes, the OCD spectrum also exhibits two dips at 212 and 222 nm, but the 
shape of the spectra does not change even after 85 minutes after hydration (Figure 3-7D), 
suggesting that the peptide remains oriented parallel to the membrane. 
Insights from a Pbound:Lipid analysis 
Since pore-formation must be mediated by peptides that are bound to vesicles, we show the 
leakage as a function of peptide bound per lipid in Figure 3-8. No leakage is observed when few 
peptides are bound to vesicles of any lipid composition. As the number of peptides bound per 
vesicle increases, leakage increases. At 500 peptides bound per vesicle, pHD15 induces 100% 
leakage for most lipid compositions. The peptide is most potent in POPC and 10% POPG, for 
which 50% leakage occurs at about 100 bound peptides per vesicle. The peptides are less potent 
in 10% POPS vesicles, for which 50% leakage occurs at about 460 bound peptides per vesicle. 
When we are varying the chain length, we find that pHD15 is most potent in C14 membranes, for 
which 50% leakage occurs at about 190 bound peptides per vesicle, and least potent for C20 




Figure 3-8: Activity versus bound peptide per lipid for various lipid compositions. 
The leakage as a function of the number of peptides bound per lipid in POPC, 10% POPS, and 





Here we have shown that pHD15 retains its pH-sensitive binding and activity in membranes with 
anionic headgroups and various acyl chain lengths. We have also shown that the peptide is 
exquisitely sensitive to lipid composition. 
 pHD15 partitions equally favorably to membranes composed of neutral and anionic 
headgroups. Despite this, pHD15 is consistently less active in 10% POPS membranes than in 
10% POPG or POPC membranes. We can understand pHD15’s behavior with a model that 
describes the steps leading to pore-formation that was proposed by Cymer et al135. In this model, 
the peptides begin unfolded in solution, partition to membranes, fold into alpha helices, insert to 
be perpendicular to the plane of the bilayer, and associate to form pores. For pHD15, we have 
seen that binding and folding are equally favorable in neutral and anionic membranes, as 
expected, due to the partitioning-folding coupling. The finding that the early steps of pore-
formation are not hindered by anionic headgroups suggests that the latter steps in pore-formation, 
such as insertion or association, are inhibited. PS is known to form interheadgroup hydrogen 
bonds136, so it is possible that PS sequesters the peptide in a surface bound orientation, limiting 
the peptide’s ability to insert into PS membranes when PS is present137. Furthermore, the peptide 
may favor peptide-lipid interactions versus peptide-peptide interactions, limiting peptide 
association. In either case, the result is that less pores will form in membranes with PS 
headgroups. 
Both pHD15’s binding and leakage are decreased in thicker membranes. Leakage and 
insertion of the peptide into membranes is nearly obliterated in thick membranes. Taken together, 
the binding, OCD, and leakage data suggest that binding to thin and thick membranes are 
fundamentally different processes. For the thinnest membranes, binding is a cooperative process 
in which peptides insert into the membrane and form pores. For the thickest membranes, 
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however, binding is an anticooperative process in which peptides orient parallel to the surface of 
the membrane, and do not form pores. Intriguingly, this is the first observed instance in which the 
pHD peptides work anticooperatively, or are inhibited from forming pores. Anticooperativity 
could be a consequence of peptide that is accumulating on the surface of thick membranes. Since 
pHD15 has four basic side chains, it is likely that the peptide is charged upon binding under 
acidic conditions. The accumulation of charged peptide could result in the electrostatic repulsion 
of peptide away from the membrane. Furthermore, as the peptides bind and accumulate, oriented 
parallel to the surface of the membrane, the interface may experience packing stress. The binding 
of additional peptide would be less favorable. 
Conclusion 
These studies have uncovered intriguing effects with no precedent in the literature, to the 
best of our knowledge. Due to the complexity of the interactions between peptide and lipids, and 
effects of pH, they warrant further investigation by molecular dynamic simulations.  
We have found that pHD15 is most potent in POPC membranes, the lipid composition 
used when screening for the peptides. This work highlights the power of synthetic molecular 
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